<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Perioperative dexmedetomidine for acute pain after abdominal surgery in adults - Jessen Lundorf, L - 2016 | Cochrane Library</title> <meta content="Perioperative dexmedetomidine for acute pain after abdominal surgery in adults - Jessen Lundorf, L - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010358.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Perioperative dexmedetomidine for acute pain after abdominal surgery in adults - Jessen Lundorf, L - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010358.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010358.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Perioperative dexmedetomidine for acute pain after abdominal surgery in adults" name="citation_title"/> <meta content="Luise Jessen Lundorf" name="citation_author"/> <meta content="Herlev University Hospital" name="citation_author_institution"/> <meta content="hansenluise@hotmail.com" name="citation_author_email"/> <meta content="Helene Korvenius Nedergaard" name="citation_author"/> <meta content="Lillebaelt Hospital" name="citation_author_institution"/> <meta content="Ann Merete Møller" name="citation_author"/> <meta content="University of Copenhagen Herlev Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD010358.pub2" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/02/18" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010358.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010358.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010358.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Abdomen [*surgery]; Acute Pain [*drug therapy]; Analgesics, Non‐Narcotic [adverse effects, *therapeutic use]; Analgesics, Opioid [administration &amp; dosage]; Dexmedetomidine [adverse effects, *therapeutic use]; Fentanyl [therapeutic use]; Pain Measurement; Pain, Postoperative [*drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010358.pub2&amp;doi=10.1002/14651858.CD010358.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="WbpyPs9C";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010358\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010358\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","pt","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010358.pub2",title:"Perioperative dexmedetomidine for acute pain after abdominal surgery in adults",firstPublishedDate:"Feb 18, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Anaesthesia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WbpyPs9C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010358.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010358.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010358.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010358.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010358.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010358.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010358.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010358.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010358.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010358.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6877 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010358.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-sec-0094"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-sec-0086"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/appendices#CD010358-sec-0099"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/table_n/CD010358StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/table_n/CD010358StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Perioperative dexmedetomidine for acute pain after abdominal surgery in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/information#CD010358-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Luise Jessen Lundorf</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/information#CD010358-cr-0003">Helene Korvenius Nedergaard</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010358.pub2/information#CD010358-cr-0004">Ann Merete Møller</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/information/en#CD010358-sec-0120">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 18 February 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010358.pub2">https://doi.org/10.1002/14651858.CD010358.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010358-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010358-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010358-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010358-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010358-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD010358-abs-0002">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010358-abs-0001" lang="en"> <section id="CD010358-sec-0001"> <h3 class="title" id="CD010358-sec-0001">Background</h3> <p>Acute postoperative pain is still an issue in patients undergoing abdominal surgery. Postoperative pain and side effects of analgesic treatment, in particular those of opioids, need to be minimized. Opioid‐sparing analgesics, possibly including dexmedetomidine, seem a promising avenue by which to improve postoperative outcomes. </p> </section> <section id="CD010358-sec-0002"> <h3 class="title" id="CD010358-sec-0002">Objectives</h3> <p>Our primary aim was to determine the analgesic efficacy and opioid‐sparing effect of perioperative dexmedetomidine for acute pain after abdominal surgery in adults. </p> <p>Secondary aims were to establish effects of dexmedetomidine on postoperative nausea and vomiting (PONV), gastrointestinal function and mobilization, together with the side effect profile of dexmedetomidine. </p> </section> <section id="CD010358-sec-0003"> <h3 class="title" id="CD010358-sec-0003">Search methods</h3> <p>We searched the following databases: Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, Institute for Scientific Information (ISI), Web of Science and Cumulative Index to Nursing and Allied Health Literature (CINAHL), and reference lists of articles to May 2014. We searched the Science Citation Index, ClinicalTrials.gov and Current Controlled Trials, and we contacted pharmaceutical companies to identify unpublished and ongoing studies. We applied no language restrictions. We reran the search in May 2015 and found nine studies of interest. We will deal with the studies of interest when we update the review. </p> </section> <section id="CD010358-sec-0004"> <h3 class="title" id="CD010358-sec-0004">Selection criteria</h3> <p>We included randomized, controlled trials of perioperative dexmedetomidine versus placebo or other drug during abdominal surgery in adults. Trials included one of the following outcomes: amount of 'rescue' opioid, postoperative pain, time to 'rescue' analgesia, participants requiring 'rescue' analgesia, postoperative sedation, PONV, time to first passage of flatus and stool or time to first out‐of‐bed mobilization. </p> </section> <section id="CD010358-sec-0005"> <h3 class="title" id="CD010358-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened the titles and abstracts for eligibility. We retrieved full trial reports if necessary, and we extracted relevant data from the included studies using a data collection form and assessed risk of bias. We resolved disagreements by discussion with the third review author. We sought additional information of relevance for risk of bias assessment or extraction of data by contacting study authors or, if necessary, co‐authors from present or former studies. </p> </section> <section id="CD010358-sec-0006"> <h3 class="title" id="CD010358-sec-0006">Main results</h3> <p>Our systematic review included seven studies with a total of 492 participants. We included 422 participants in our analysis. Thirteen studies are awaiting classification. For the comparison dexmedetomidine versus placebo (six studies, 402 participants), most studies found a reduction in 'rescue' opioid consumption in the first 24 hours after surgery, together with in general no clinically important differences in postoperative pain (visual analogue scale (VAS) 0 to 100 mm, where 0 = no pain and 100 = worst imaginable pain) in the first 24 hours after surgery ‐ except for one study (80 participants) with a reduction in VAS pain at two hours after surgery in favour of dexmedetomidine, with a mean difference of ‐30.00 mm (95% confidence interval (CI) ‐38.25 to ‐21.75). As the result of substantial heterogeneity, pooling of data in statistical meta‐analyses was not appropriate. The quality of evidence was very low for our primary outcomes because of imprecision of results and risk of bias. Regarding our secondary aims, evidence was too scant in general to allow robust conclusions, or the estimates too imprecise or of poor methodological quality. Regarding adverse effects, low quality data (one study, 80 participants) suggest that the proportion of participants with hypotension requiring intervention was slightly higher in the high‐dose dexmedetomidine group with a risk ratio of 2.50 (95% CI 0.94 to 6.66), but lower doses of dexmedetomidine led to no differences compared with control. Evidence for the comparison dexmedetomidine versus fentanyl was insufficient to permit robust conclusions (one study, 20 participants). </p> </section> <section id="CD010358-sec-0007"> <h3 class="title" id="CD010358-sec-0007">Authors' conclusions</h3> <p>Dexmedetomidine, when administered perioperatively for acute pain after abdominal surgery in adults, seemed to have some opioid‐sparing effect together with in general no important differences in postoperative pain when compared with placebo. However the quality of the evidence was very low as the result of imprecision, methodological limitations and substantial heterogeneity among the seven included studies. The clinical importance for patients is uncertain, in as much as the influence of dexmedetomidine on patient‐important outcomes such as gastrointestinal function, mobilization and adverse effects could not be satisfactorily determined. All included studies were relatively small, and publication bias could not be ruled out. Applicability of evidence was limited to middle‐aged participants who were relatively free of co‐morbidity and were undergoing elective abdominal surgery. A potential bias was a considerable quantity of unobtainable data from studies with mixed surgery. To detect and investigate patient‐important outcomes, larger studies with longer periods of follow‐up are needed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010358-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010358-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010358-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010358-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010358-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010358-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD010358-abs-0006">Português</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010358-abs-0005" lang="en"> <h3>Dexmedetomidine for prevention of acute pain after abdominal surgery in adults</h3> <p><b>Background and review question</b> </p> <p>Acute pain after surgery is a problem for patients undergoing abdominal surgery. In addition to postoperative pain, the side effects of treatment with pain killers, in particular those of opioids (drugs resembling morphine), need to be reduced. Dexmedetomidine is an opioid sparing drug (reduces the need for opioids). We reviewed the evidence about the effectiveness of dexmedetomidine in reducing the need for opioids and in preventing acute pain after abdominal surgery in adults. We wanted to discover how safe dexmedetomidine was and whether it was effective in preventing some of the known side effects of opioids, such as nausea and vomiting, reduced bowel function and delayed mobilization (getting up and moving around) after abdominal surgery. </p> <p><b>Study characteristics</b> </p> <p>Evidence is current to May 2014. We included seven studies with 492 participants from five different countries and included 422 participants in our analysis. Most participants were middle‐aged. Participants had almost no diseases other than their reason for having surgery. The type of surgery was planned abdominal surgery. Three of the seven studies looked only at obesity surgery. Participants received dexmedetomidine right before or during their abdominal surgery. Six studies compared dexmedetomidine with no treatment, and one small study compared dexmedetomidine with fentanyl (a strong opioid). </p> <p>We reran the search in May 2015 and found nine studies of interest, which we will discuss when we update the review. In total, 13 studies are awaiting classification. </p> <p><b>Key results and quality of the evidence</b> </p> <p>Most of the studies that compared dexmedetomidine with no treatment found that dexmedetomidine reduced the need for opioids for treating pain for 24 hours after surgery. During the same period, no important differences in pain were noted, except one study (80 participants) showed a reduction in intensity of pain at two hours after surgery with dexmedetomidine. The quality of the evidence was very low because the results were not similar across studies, and because some studies were poorly conducted. The influence of dexmedetomidine on postoperative nausea and vomiting could not be determined because results were not similar across studies. No conclusion could be made for bowel function and mobilization and side effects such as postoperative sedation, as data were insufficient. One study with 80 participants reported a higher rate of low blood pressure ('low' meaning that medication was required) for participants receiving a high dose of dexmedetomidine compared with no treatment, but for lower doses of dexmedetomidine, they noted no differences compared with no treatment. </p> <p>For the comparison dexmedetomidine versus fentanyl, data were insufficient to allow conclusions (only one small study). </p> <p><b>Conclusion</b> </p> <p>Dexmedetomidine ‐ compared with no treatment ‐ seemed to reduce the need for opioids without worsening the experience of postoperative pain after abdominal surgery in adults. However, the quality of evidence was very low because studies were poorly conducted and because results were not similar across studies. The importance of these findings for patients was also uncertain because the influence of dexmedetomidine on bowel function, mobilization and adverse effects could not be properly determined.The seven included studies were small, so side effects associated with use of dexmedetomidine may be greater than this review reported. In addition, we could not obtain relevant data from several studies because investigators mixed abdominal surgery with other types of surgery. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010358-sec-0094" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010358-sec-0094">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010358-sec-0167">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010358-sec-0094"></div> <h3 class="title" id="CD010358-sec-0095">Implications for practice</h3> <section id="CD010358-sec-0095"> <p>The findings of our systematic review suggest that dexmedetomidine, compared with placebo, seems to have analgesic and opioid‐sparing effects, but when the comparison is made with placebo, this is hardly surprising. The analgesic effects seemed to last up to 24 hours after surgery, even though half of the dexmedetomidine is eliminated from the organism within two hours. Pooled quantification of the opioid‐sparing effect was not possible in this review, but the opioid‐sparing effect was around or above 25% for most studies during 24 hours after surgery, without a significant difference in postoperative pain. For our main outcomes, the quality of the evidence was very low according to the GRADE system, signifying that "we are very uncertain about the estimate" (<a href="./references#CD010358-bbs2-0070" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians. BMJ2008;336:995‐8. [MEDLINE: 18456631] '>Guyatt 2008</a>). We cannot rule out a small‐studies effect with overestimation of treatment effects and underreporting of relevant side effects. Applicability (external validity) of the results was limited to middle‐aged participants with a minimum of co‐morbidity when the reason for abdominal surgery was not considered, and a relative overweight of bariatric surgery and thus adipose participants was noted. </p> <p>Our primary outcomes cannot be separated from one another in the evaluation of pain and treatment of pain, but what matters to patients is that they experience a minimum of pain, and in this regard, a presumed opioid‐sparing effect of a treatment in itself is not important to patients. What is more essential involves a reduction in opioid‐related side effects, improved postoperative recovery and a minimum of other side effects and complications. With selection of our secondary outcomes (postoperative sedation, postoperative nausea and vomiting, gastrointestinal function and mobilization), we had hoped to be able to evaluate some of these important issues for patients, but the included studies provided insufficient data. With practical use of dexmedetomidine, one should still be prepared that side effects, particularly hypotension and bradycardia, could require intervention. The optimal dosage, timing and route of administration in the perioperative use of dexmedetomidine have not been settled. </p> <p>A comparison of dexmedetomidine with other analgesic agents has not been possible, as only one of our included studies (20 participants) provided data, with fentanyl as a comparison. </p> </section> <h3 class="title" id="CD010358-sec-0096">Implications for research</h3> <section id="CD010358-sec-0096"> <p>One great limitation of this systematic review was that our choice to exclude surgery other than abdominal entailed that a great deal of available data could not be included because they were derived from studies with mixed surgery (or unspecified), and without the opportunity to obtain individual participant data. It is not in our ability to judge whether it can be recommended that future research should be more restricted to specific types of surgery, but it is obvious that future updates of this review would benefit from more research restricted to abdominal surgery. Furthermore, it is likely that studies that investigate mixed surgery, comprising for example minor or superficial surgery together with abdominal surgery, may be unlikely to contribute to patient‐important outcomes and side effects that are particularly relevant in abdominal surgery, such as paralytic ileus, time to mobilization or urinary retention. </p> <p>Concerning abdominal surgery, a more exact quantification of the opioid‐sparing effects of dexmedetomidine would of course be relevant for comparison with other analgesic treatments, but this should not be a stand‐alone aim of future research. Future investigators must focus on patient‐important issues, including outcomes with a longer period of follow‐up. Secondary outcomes of this review should not be considered as a gold standard check list for future research, but merely as examples of relevant outcomes to patients. One could think of many other highly important outcomes, such as postoperative infection, rehospitalization, delirium, patient satisfaction, chronic postoperative pain and of course mortality. Larger studies are needed to detect such outcomes. </p> <p>To pool data in reviews and meta‐analyses and compare study results, it is important to seek consensus concerning evaluation methods and parameters for outcomes. Areas for possible improvement include evaluation of sedation, the distinction between VAS pain at rest and at movement, a systematic reporting of baseline data for evaluated outcomes and a consensus to report postoperative nausea and vomiting as primarily one outcome ‐ PONV ‐ not separately as nausea and vomiting (because one cannot know if some participants have both and thereby will count double in pooling of data, thus causing a unit of analysis error with a meta‐analysis). Furthermore, a report of only VAS pain should never be provided without a report of amount of 'rescue' analgesia and vice versa. </p> <p>A challenge in performing meta‐analyses and reviews of postoperative pain treatment is the great diversity among 'rescue' analgesia regimens. Reports of the criteria for administering 'rescue' analgesia provided together with the frequency of evaluation of pain are relevant data for a systematic review. </p> <p>Concerning the methodological quality of studies, the description of random sequence generation, details of blinding methods, allocation concealment methods, etc, should be improved. Without this detailed information, the judgement 'unclear risk of bias' may cover studies that should not have been downgraded and studies that should have been even further downgraded. </p> <p>The optimal dosage, timing and route of administration for the perioperative use of dexmedetomidine in abdominal surgery remain to be clarified to show a minimum of harms and a maximum of benefit. Comparisons of dexmedetomidine with other analgesic agents are as yet sparse. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010358-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010358-sec-0029"></div> <div class="table" id="CD010358-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Dexmedetomidine for postoperative pain</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> adults having abdominal surgery </p> <p><b>Setting:</b> hospital </p> <p><b>Intervention:</b> perioperative dexmedetomidine </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="5" rowspan="1" valign=""> <p><b>Comparison: dexmedetomidine vs placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Effect<sup>a</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Number of participants (number of studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b> Quality of evidence (GRADE)*</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Amount of 'rescue' opioid (intravenous morphine equivalents, mg) 24 hours after surgery (MD, 95% CI) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Three of four studies found a reduction in 'rescue' opioid consumption (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>). One study showed reduced need for non‐opioid analgesia in the dexmedetomidine group and no difference in consumption of 'rescue' opioid (<a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>, 42 participants) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>259 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 3 levels because of serious risk of bias (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>), serious imprecision of results (<a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) and serious inconsistency arising from heterogeneity in effect estimates </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative pain (VAS 0 to 100 mm, visual analogue scale from 0 = no pain to 100 = worst imaginable pain) 24 hours after surgery (MD, 95% CI) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No clinically important difference in VAS postoperative pain</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>259 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 3 levels because of serious risk of bias (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>), serious imprecision and serious inconsistency arising from heterogeneity in amount of 'rescue' analgesia between studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative sedation 12 hours after surgery (units of RSS, Ramsay Sedation Scale from 1 = Anxious or agitated or restless to 6 = Unresponsive) (MD, 95% CI) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Quantity of data was too small to allow a robust conclusion. The only study reporting data found an increased level of sedation with dexmedetomidine, with a mean difference in RSS 1 to 6 of 1.60 units (95% CI 1.49 to 1.71) (<a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>80 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 3 levels because of serious risk of bias and serious imprecision (small quantity of data) (<a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative nausea and vomiting (PONV) (RR, 95% CI)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>One study found reduced risk of PONV with dexmedetomidine (RR 0.54, 95% CI 0.33 to 0.87; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>, 77 participants) and at the same time reduced need for antiemetics. Two other studies found risk ratios of PONV close to favouring neither dexmedetomidine nor placebo (RR 0.67, 95% CI 0.12 to 3.78 for <a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>, 80 participants) (RR 0.50, 95% CI 0.17 to 1.48 for <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>, 60 participants) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>217 (3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p><b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 2 levels because of serious inconsistency in outcome definition (PONV separated in nausea and vomiting) (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) and risk of bias (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time to first passage of flatus (hours, MD, 95% CI)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Quantity of data was too small to allow a robust conclusion. The only study reporting data found no difference in time to first passage of flatus (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>77 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p><b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 2 levels because of very serious imprecision (small quantity of data)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time to first passage of stool (hours, MD, 95% CI)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time to first out‐of‐bed mobilization (hours, MD, 95% CI)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Quantity of data was too small to allow a robust conclusion. The only study reporting data found no difference in time to first out‐of‐bed mobilization (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>77 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p><b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 2 levels because of very serious imprecision (small quantity of data)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>MD</b> : mean difference; <b>CI</b> : confidence interval; <b>RR</b> : risk ratio; <b>NR</b>: no data reported </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>Performing meta‐analyses was not appropriate for any outcome. All studies had a relatively small number of participants and substantial heterogeneity for three main reasons: </p> <p>1. Methodological limitations in several studies (high or unclear risk of bias)</p> <p>2. Clinical variation with great difference in amount of 'rescue' analgesia, type of surgery, body mass index, route and timing of administration of dexmedetomidine and anaesthetic agents, etc </p> <p>3. Statistical variation with relatively great imprecision in results and a high I<sup>2</sup> statistic for several outcomes </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010358-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010358-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010358-sec-0145">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD010358-sec-0030"></div> <section id="CD010358-sec-0031"> <h3 class="title" id="CD010358-sec-0031">Description of the condition</h3> <p>Acute postoperative pain is still an issue in patients undergoing abdominal surgery. Inefficient relief of pain may be associated with reduced mobility, postoperative complications and prolongation of hospital stay (<a href="./references#CD010358-bbs2-0074" title="KehletH , DahlJB . Anaesthesia, surgery, and challenges in postoperative recovery. Lancet2003;362(9399):1921–8. ">Kehlet 2003</a>). Although different analgesic agents and techniques are available, opioids remain one of the cornerstones of postoperative pain treatment because of their excellent analgesic properties. Nevertheless, opioids have worrisome side effects such as nausea, vomiting, gastrointestinal dysfunction, drowsiness, urinary retention and respiratory depression. These adverse effects may sometimes outweigh analgesic benefits, as they may impair postoperative rehabilitation as well (<a href="./references#CD010358-bbs2-0062" title="BonnetF , MarretE . Postoperative pain management and outcome after surgery. Best Practice &amp; Research Clinical Anaesthesiology2007;21(1):99–107. ">Bonnet 2007</a>). The gastrointestinal side effects of opioids are particularly undesirable after abdominal surgery, which in itself is associated with paralytic ileus. It has been recommended to use opioids after abdominal surgery only when non‐opioid drugs provide insufficient analgesia (<a href="./references#CD010358-bbs2-0074" title="KehletH , DahlJB . Anaesthesia, surgery, and challenges in postoperative recovery. Lancet2003;362(9399):1921–8. ">Kehlet 2003</a>). Consequently, there is a need to develop and extend the use of non‐opioid analgesia for acute pain after abdominal surgery. </p> </section> <section id="CD010358-sec-0032"> <h3 class="title" id="CD010358-sec-0032">Description of the intervention</h3> <p>Dexmedetomidine is an alpha‐2 adrenoceptor agonist with sedative, analgesic, sympatholytic and anxiolytic properties. Indications for use are presently limited to sedation in intensive care units (ICUs) (<a href="./references#CD010358-bbs2-0067" title="European Medicines Agency. Dexdor product information. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_‐_Product_Information/human/002268/WC500115631.pdf. (accessed 19 October 2014). ">Dexdor product information</a>; <a href="./references#CD010358-bbs2-0084" title="Hospira , Inc . Precedex prescribing information. http://www.precedex.com/wp‐content/uploads/wEN‐3411_PrecedexPI.PDF. (accessed 19 October 2014). ">Precedex prescribing information</a>) and sedation in surgical patients who are not intubated (<a href="./references#CD010358-bbs2-0084" title="Hospira , Inc . Precedex prescribing information. http://www.precedex.com/wp‐content/uploads/wEN‐3411_PrecedexPI.PDF. (accessed 19 October 2014). ">Precedex prescribing information</a>). A recent clinical practice guideline suggests dexmedetomidine for the treatment of delirium in the ICU (<a href="./references#CD010358-bbs2-0059" title="BarrJ , FraserGL , PuntilloK , ElyEW , GelinasC , DastaJF , et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit, 1 ed. Critical Care Medicine2013;41:263‐306. ">Barr 2013</a>). Dexmedetomidine is presently licensed for intravenous use only, but other modes of administration are being explored, including intramuscular, epidural, intra‐articular, buccal and intranasal routes (<a href="./references#CD010358-bbs2-0063" title="ChanAK , CheungCW , ChongYK . Alpha‐2 agonists in acute pain management. Expert Opinion on Pharmacotherapy2010;11(17):2849‐68. [DOI: 10.1517/14656566.2010.511613] ">Chan 2010</a>). The most common adverse effects of dexmedetomidine are hypotension, bradycardia, hypertension and nausea; less common adverse effects include atrial fibrillation, fever and dry mouth, and cases of sinus arrest have been reported (<a href="./references#CD010358-bbs2-0067" title="European Medicines Agency. Dexdor product information. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_‐_Product_Information/human/002268/WC500115631.pdf. (accessed 19 October 2014). ">Dexdor product information</a>; <a href="./references#CD010358-bbs2-0084" title="Hospira , Inc . Precedex prescribing information. http://www.precedex.com/wp‐content/uploads/wEN‐3411_PrecedexPI.PDF. (accessed 19 October 2014). ">Precedex prescribing information</a>). Infusion of dexmedetomidine exceeding 24 hours is not recommended because of risk of agitation and respiratory failure (<a href="./references#CD010358-bbs2-0084" title="Hospira , Inc . Precedex prescribing information. http://www.precedex.com/wp‐content/uploads/wEN‐3411_PrecedexPI.PDF. (accessed 19 October 2014). ">Precedex prescribing information</a>); this precaution is not stated in <a href="./references#CD010358-bbs2-0067" title="European Medicines Agency. Dexdor product information. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_‐_Product_Information/human/002268/WC500115631.pdf. (accessed 19 October 2014). ">Dexdor product information</a>. The same drug dexmedetomidine is sold as Precedex and Dexdor under two different regulatory authorities. </p> </section> <section id="CD010358-sec-0033"> <h3 class="title" id="CD010358-sec-0033">How the intervention might work</h3> <p>The analgesic properties of dexmedetomidine probably involve both peripheral and central mechanisms. Centrally, the antinociceptive effect seems to be related to stimulation of alpha‐2 adrenoceptors located both at the spinal level in neurons of the dorsal horn and at a supraspinal level in the locus coeruleus. The peripheral analgesic mechanism is not entirely elucidated (<a href="./references#CD010358-bbs2-0063" title="ChanAK , CheungCW , ChongYK . Alpha‐2 agonists in acute pain management. Expert Opinion on Pharmacotherapy2010;11(17):2849‐68. [DOI: 10.1517/14656566.2010.511613] ">Chan 2010</a>). Dexmedetomidine is eight times more selective of alpha‐2 adrenoceptors than clonidine; thus it is expected to be a more effective analgesic agent (<a href="./references#CD010358-bbs2-0063" title="ChanAK , CheungCW , ChongYK . Alpha‐2 agonists in acute pain management. Expert Opinion on Pharmacotherapy2010;11(17):2849‐68. [DOI: 10.1517/14656566.2010.511613] ">Chan 2010</a>). </p> <p>Several trials have demonstrated a significant opioid‐sparing effect of dexmedetomidine (<a href="./references#CD010358-bbs2-0042" title="ArainSR , RuehlowRM , UhrichTD , EbertTJ . The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesthesia and Analgesia2004;98:153‐8. ">Arain 2004</a>; <a href="./references#CD010358-bbs2-0021" title="GurbetA , Basagan‐MogolE , TurkerG , UgunF , KayaFN , OzcanB . Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Canadian Journal of Anaesthesia2006;53(7):646‐52. ">Gurbet 2006</a>; <a href="./references#CD010358-bbs2-0077" title="LinTF , YehYC , LinFS , WangYP , LinCJ , SunWZ , et al. Effect of combining dexmedetomidine and morphine for intravenous patient‐controlled analgesia. British Journal of Anaesthesia2009;102(1):117‐22. [PMID: 18987053] ">Lin 2009</a>; <a href="./references#CD010358-bbs2-0050" title="UnlugencH , GunduzM , GulerT , YagmurO , IsikG . The effect of pre‐anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient‐controlled morphine. European Journal of Anaesthesiology2005;22(5):386‐91. [DOI: 10.1017/S0265021505000669] ">Unlugenc 2005</a>; <a href="./references#CD010358-bbs2-0089" title="VandermeulenE . Systemic analgesia and co‐analgesia. Acta Anaesthesiologica Belgica2006;57(2):113‐20. ">Vandermeulen 2006</a>). A great benefit is that dexmedetomidine does not seem to compromise respiratory function (<a href="./references#CD010358-bbs2-0081" title="MantzJ , JosserandJ , HamadaS . Dexmedetomidine: new insights. European Journal of Anaesthesiology2011;28(1):3‐6. [PMID: 20881501] ">Mantz 2011</a>; <a href="./references#CD010358-bbs2-0090" title="VillelaNR , Nascimento JúniorP . Dexmedetomidine in anesthesiology [in Portuguese]. Revista Brasileira de Anestesiologia2003;53(1):97‐113. [PMID: 19475263] ">Villela 2003</a>). Other possible benefits include neuroprotection (attenuation of delirium) and cardioprotection (prevention of myocardiac ischaemia), although these have not been convincingly demonstrated (<a href="./references#CD010358-bbs2-0060" title="BiccardBM , GogaS , deBeursJ . Dexmedetomidine and cardiac protection for non‐cardiac surgery: a meta‐analysis of randomised controlled trials. Anaesthesia2008;63(1):4‐14. [PMID: 18086064] ">Biccard 2008</a>; <a href="./references#CD010358-bbs2-0065" title="ChrysostomouC , SchmittCG . Dexmedetomidine: sedation, analgesia and beyond. Expert Opinion on Drug Metabolism &amp; Toxicology2008;4(5):619‐27. [PMID: 18484919] ">Chrysostomou 2008</a>; <a href="./references#CD010358-bbs2-0081" title="MantzJ , JosserandJ , HamadaS . Dexmedetomidine: new insights. European Journal of Anaesthesiology2011;28(1):3‐6. [PMID: 20881501] ">Mantz 2011</a>; <a href="./references#CD010358-bbs2-0093" title="WijeysunderaDN , BenderJS , BeattieWS . Alpha‐2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD004126.pub2] ">Wijeysundera 2009</a>). </p> </section> <section id="CD010358-sec-0034"> <h3 class="title" id="CD010358-sec-0034">Why it is important to do this review</h3> <p>To improve postoperative outcomes after abdominal surgery, both postoperative pain and side effects of analgesic treatment, in particular those of opioids, must be minimized. The physiological mechanisms of postoperative pain operate at several different levels; thus multi‐modal or balanced analgesia is generally recommended (<a href="./references#CD010358-bbs2-0074" title="KehletH , DahlJB . Anaesthesia, surgery, and challenges in postoperative recovery. Lancet2003;362(9399):1921–8. ">Kehlet 2003</a>). In abdominal surgery, the opioid side effects are particularly undesirable. As side effects increase at higher doses (<a href="./references#CD010358-bbs2-0062" title="BonnetF , MarretE . Postoperative pain management and outcome after surgery. Best Practice &amp; Research Clinical Anaesthesiology2007;21(1):99–107. ">Bonnet 2007</a>; <a href="./references#CD010358-bbs2-0082" title="MarretE , KurdiO , ZuffereyP , BonnetF . Effects of nonsteroidal antiinflammatory drugs on patient‐controlled analgesia morphine side effects: meta‐analysis of randomized controlled trials. Anesthesiology2005;102:1249–60. ">Marret 2005</a>), opioid‐sparing analgesics seem a promising avenue by which postoperative outcomes can be improved. In this context, it is appropriate to examine critically the risks and benefits of dexmedetomidine. </p> <p>As a result of its opioid‐sparing effect, it is plausible that patients treated with dexmedetomidine after abdominal surgery will experience better gastrointestinal function (less nausea and vomiting and shorter duration of paralytic ileus). Thus, there is reason to believe that the use of dexmedetomidine is associated with fewer postoperative complications and facilitates recovery after abdominal surgery. This assumption needs to be investigated, as it has been shown that greater analgesic efficacy does not automatically translate into improved clinical postoperative outcomes such as recovery of bowel function, active mobilization and fewer organ‐related complications (<a href="./references#CD010358-bbs2-0079" title="LiuSS , WuCL . Effect of postoperative analgesia on major postoperative complications: a systematic update of the evidence. Anesthesia and Analgesia2007;104:689–702. ">Liu 2007</a>; <a href="./references#CD010358-bbs2-0092" title="WhitePF , KehletH . Improving postoperative pain management: what are the unresolved issues?. Anesthesiology2010;112(1):220‐5. ">White 2010</a>). Moreover, studies differ as to whether postoperative recovery is facilitated by the use of dexmedetomidine (<a href="./references#CD010358-bbs2-0088" title="TanJA , HoKM . Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta‐analysis. Intensive Care Medicine2010;36(6):926‐39. [PMID: 20376429] ">Tan 2010</a>; <a href="./references#CD010358-bbs2-0050" title="UnlugencH , GunduzM , GulerT , YagmurO , IsikG . The effect of pre‐anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient‐controlled morphine. European Journal of Anaesthesiology2005;22(5):386‐91. [DOI: 10.1017/S0265021505000669] ">Unlugenc 2005</a>). </p> <p>Another question that needs to be addressed is whether the analgesic efficacy of dexmedetomidine comes at the cost of problematic side effects, in particular, postoperative sedation and cardiovascular side effects including bradycardia and hypotension (<a href="./references#CD010358-bbs2-0042" title="ArainSR , RuehlowRM , UhrichTD , EbertTJ . The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesthesia and Analgesia2004;98:153‐8. ">Arain 2004</a>; <a href="./references#CD010358-bbs2-0060" title="BiccardBM , GogaS , deBeursJ . Dexmedetomidine and cardiac protection for non‐cardiac surgery: a meta‐analysis of randomised controlled trials. Anaesthesia2008;63(1):4‐14. [PMID: 18086064] ">Biccard 2008</a>; <a href="./references#CD010358-bbs2-0077" title="LinTF , YehYC , LinFS , WangYP , LinCJ , SunWZ , et al. Effect of combining dexmedetomidine and morphine for intravenous patient‐controlled analgesia. British Journal of Anaesthesia2009;102(1):117‐22. [PMID: 18987053] ">Lin 2009</a>; <a href="./references#CD010358-bbs2-0088" title="TanJA , HoKM . Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta‐analysis. Intensive Care Medicine2010;36(6):926‐39. [PMID: 20376429] ">Tan 2010</a>). With regards to postoperative nausea and vomiting (PONV), some studies show that dexmedetomidine has a lower incidence of nausea compared with opioids (<a href="./references#CD010358-bbs2-0077" title="LinTF , YehYC , LinFS , WangYP , LinCJ , SunWZ , et al. Effect of combining dexmedetomidine and morphine for intravenous patient‐controlled analgesia. British Journal of Anaesthesia2009;102(1):117‐22. [PMID: 18987053] ">Lin 2009</a>). Other studies show that dexmedetomidine has no effect on the incidence of opioid‐induced bowel dysfunction despite its opioid‐sparing properties (<a href="./references#CD010358-bbs2-0089" title="VandermeulenE . Systemic analgesia and co‐analgesia. Acta Anaesthesiologica Belgica2006;57(2):113‐20. ">Vandermeulen 2006</a>). </p> <p>Therefore, this systematic review is needed in order to clarify the analgesic properties of dexmedetomidine when used perioperatively in abdominal surgery, as well as to establish the harms and benefits associated with its use. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010358-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010358-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010358-sec-0150">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010358-sec-0035"></div> <p>Our primary aim was to determine the analgesic efficacy and opioid‐sparing effect of perioperative dexmedetomidine for acute pain after abdominal surgery in adults. </p> <p>Secondary aims were to establish effects of dexmedetomidine on PONV, gastrointestinal function and mobilization, together with the side effect profile of dexmedetomidine. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010358-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010358-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010358-sec-0151">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010358-sec-0036"></div> <section id="CD010358-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010358-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials (RCTs) evaluating the effect of dexmedetomidine for acute pain after abdominal surgery in adults, irrespective of language and publication status. We would have included cluster‐randomized trials and factorial trials (in a factorial trial, at least two intervention comparisons are carried out simultaneously), had we identified any. </p> <p>We excluded cross‐over trials, quasi‐randomized trials and all non‐randomized trials.</p> </section> <section id="CD010358-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included adult participants undergoing all types of abdominal surgery, including both open and laparoscopic procedures. We included general and regional forms of anaesthesia. We defined abdominal surgery as surgery to intra‐abdominal organs, excluding gynaecological, urological, vascular and superficial surgery (such as hernia repair). </p> </section> <section id="CD010358-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We compared perioperative (preoperative, intraoperative or postoperative) administration of dexmedetomidine with other treatments or placebo (with 'rescue' medication). We included all modes of administration and all variations of dosage, frequency and duration. </p> <p>We included interventions combining dexmedetomidine with another treatment if that same treatment, without dexmedetomidine, was given to the control group. We also included interventions combining dexmedetomidine with another treatment if the design of the trial was factorial, and if we did not suspect any interaction between treatments. </p> </section> <section id="CD010358-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD010358-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010358-list-0001"> <li> <p>The opioid‐sparing effect of dexmedetomidine ‐ measured by amount of 'rescue' opioid, administered via any route, at three, six, 12 and 24 hours after end of surgery. </p> </li> <li> <p>The analgesic efficacy of dexmedetomidine ‐ measured at rest and on movement, as defined by study authors, by visual analogue scale (VAS) 0 to 100 mm, where 0 mm corresponds to no pain and 100 mm corresponds to worst imaginable pain. Use of a VAS scale 0 to 10 cm was converted to VAS 0 to 100 mm. We regarded any use of verbal or numerical rating scales (NRSs) from 0 to 10 as convertible with VAS. We selected the measuring time points of three, six, 12 and 24 hours after end of surgery. </p> </li> </ul> </p> </section> <section id="CD010358-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010358-list-0002"> <li> <p>Time to first request of 'rescue' analgesia.</p> </li> <li> <p>Proportion of participants needing 'rescue' analgesia.</p> </li> <li> <p>Postoperative sedation ‐ assessed by clinical measures at three, six and 12 hours after end of surgery. By 'clinical measures', we understood values estimated by observer or participant, such as the Ramsey Sedation Scale (RSS), and not by use of technology, such as the bispectral index (BIS). </p> </li> <li> <p>Proportion of participants with PONV until 24 hours after end of surgery, or proportion of participants treated with antiemetics. </p> </li> <li> <p>Time to first passage of flatus after end of surgery or proportion of participants with delay to first passage of flatus. </p> </li> <li> <p>Time to first passage of stool after end of surgery or proportion of participants with delay to first passage of stool. </p> </li> <li> <p>Time to first out‐of‐bed mobilization after end of surgery or proportion of participants with delay to first out‐of‐bed mobilization. </p> </li> <li> <p>Post‐interventional complications or adverse effects, particularly hypotension, bradycardia, delirium and respiratory failure, reported as a proportion of participants. </p> </li> </ul> </p> </section> </section> </section> <section id="CD010358-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010358-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases: Cochrane Central Register of Controlled Trials (CENTRAL; 2014, Issue 5; see <a href="./appendices#CD010358-sec-0100">Appendix 1</a>); MEDLINE, Ovid SP (1956 to May 2014; see <a href="./appendices#CD010358-sec-0101">Appendix 2</a>); EMBASE, Ovid SP (1982 to May 2014; see <a href="./appendices#CD010358-sec-0102">Appendix 3</a>); Institute for Scientific Information (ISI) Web of Science (1950 to May 2014; see <a href="./appendices#CD010358-sec-0103">Appendix 4</a>) and Cumulative Index to Nursing and Allied Health Literature (CINAHL) via EBSCO host (1980 to May 2014; see <a href="./appendices#CD010358-sec-0104">Appendix 5</a>). When searching the databases, we used both subject headings and free‐text terms. We combined our subject search terms with the Cochrane highly sensitive search strategy for identifying RCTs, as suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010358-bbs2-0071" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). We adapted our MEDLINE search strategy when searching all other databases. </p> <p>We searched the references in accepted studies for additional eligible trials.</p> <p>We reran the search in May 2015.</p> <p>We applied no language restrictions.</p> </section> <section id="CD010358-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We searched the references in accepted studies for additional eligible trials.</p> <p>We searched the Science Citation Index, <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and <a href="http://www.controlled-trials.com/mrct/" target="_blank">Current Controlled Trials</a> in August 2014 to identify additional published, unpublished and ongoing studies. </p> <p>Furthermore, we contacted the medical companies responsible for marketing of dexmedetomidine, to ask about additional and unpublished research. </p> </section> </section> <section id="CD010358-sec-0047"> <h3 class="title" id="CD010358-sec-0047">Data collection and analysis</h3> <section id="CD010358-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Two review authors (LJL, HKN) independently examined the titles and abstracts obtained by the above searches. We excluded trials that did not meet all of the eligibility criteria referred to on the data collection form (<a href="./appendices#CD010358-sec-0105">Appendix 6</a>). If a decision could not be made on the basis of the abstract alone, we retrieved the full trial report. We documented the reason for exclusion of trials when the reason for exclusion was not obvious. </p> <p>We resolved disagreements between the two review authors by consulting with a third review author (AMM). </p> <p>If a trial report provided insufficient information for a decision on inclusion, we contacted the first author of the trial. </p> <p>We (LJL, HKN) were not blinded to reference details during the selection process.</p> </section> <section id="CD010358-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (LJL, HKN) went through the full text of all included trials. We independently completed the data collection form (<a href="./appendices#CD010358-sec-0105">Appendix 6</a>) in the process of extracting data. </p> <p>Both review authors (LJL, HKN) performed a pilot test of the data collection form.</p> <p>We resolved disagreements by discussion, and if they remained unresolved, by consulting with a third review author (AMM). When disagreements remained, we contacted the first author of the relevant trial to seek further information. If we could not resolve a disagreement, we reported this in our review. </p> </section> <section id="CD010358-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (LJL, HKN) independently assessed the risk of bias for each eligible trial. We resolved disagreements by discussion with a third review author (AMM). </p> <p>We performed the assessment of risk of bias as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010358-bbs2-0071" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>We assessed the risk of bias by evaluating the following seven domains in each trial: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting and other bias. On the basis of the description of the study's approach to each domain (including relevant quotes and our comments), we made a judgement of high, low or unclear risk of bias for each domain, using the specific criteria recommended by <a href="./references#CD010358-bbs2-0071" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>. </p> <p>We originally planned to include studies in our meta‐analysis regardless of our assessment of risk of bias for an outcome as high, low or unclear. Subsequently, and if data were sufficient, we planned to perform sensitivity analyses, first by excluding studies with high risk of bias for the outcome in question, and second by excluding studies with high and unclear risk of bias. However, no meta‐analyses were appropriate. </p> </section> <section id="CD010358-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes, we chose risk ratio (RR) as the preferred effect measure. If relevant, we planned to calculate the number needed to treat for an additional beneficial outcome (NNTB) and the number needed to treat for an additional harmful outcome (NNTH), although we did not intend to incorporate these into the meta‐analyses. </p> <p>For continuous outcomes, we calculated the difference in means or the mean difference (MD) when measurement scales were similar. If measurement scales were not similar, we planned to use the standardized mean difference (SMD). </p> <p>We treated ordinal outcomes and measurement scales as continuous data.</p> </section> <section id="CD010358-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>To avoid making a unit of analysis error, we would be particularly cautious when facing a trial that did not follow a 'standard' design, meaning one measurement for each outcome for each participant in a double‐arm trial. The two following cases need to be mentioned specifically. </p> <p> <ul id="CD010358-list-0003"> <li> <p>For any study with multiple treatment arms, we tried to combine groups to create a single comparison. But if the combination of groups was not meaningful, we judged the relevance of all treatment groups for our review question. If one or several treatment arms were not relevant, we excluded these from the analysis, although we mentioned them under <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a> and evaluated whether the exclusion introduced any risk of bias. If all treatment arms were relevant to our review question, we planned to perform a multiple treatments meta‐analysis (MTM). </p> </li> </ul> <ul id="CD010358-list-0004"> <li> <p>For any study that provided multiple observations for the same outcome, we performed a separate analysis for each relevant observation, expecting this to be the case for several of our selected outcomes: amount of 'rescue' opioid (at three, six, 12 and 24 hours after surgery), postoperative pain at rest and on movement (at three, six, 12 and 24 hours after surgery) and postoperative sedation (at three, six and 12 hours after surgery). </p> </li> </ul> </p> </section> <section id="CD010358-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>For any type of missing data, we contacted the first author of the relevant trial to ask for additional information. If the contact information was not directly available, we tried to retrieve an email address or a postal address by searching the Internet, or by contacting co‐authors from present or former studies. Some attempted correspondence may not have reached the addressee. </p> <p>When we encountered missing data, we planned to perform an intention‐to‐treat (ITT) analysis if possible. If an ITT analysis was not possible, we based our analysis on available data and discussed risk of bias and the potential impact of missing data. In any meta‐analyses, we planned to perform a sensitivity analysis for missing data concerning best‐case and worst‐case scenarios. </p> </section> <section id="CD010358-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered heterogeneity arising from clinical diversity (related to participants, interventions and outcomes) and from methodological diversity (related to risk of bias) to be present a priori. We quantified statistical heterogeneity by using the I<sup>2</sup> statistic, which reflects the percentage of variability that is due to heterogeneity rather than to random error. </p> <p>We planned to perform meta‐analyses. A meta‐analysis would be appropriate, though, only if variation in results was not considerable, as judged by clinical and methodological measures and by the statistical measure of heterogeneity, the I<sup>2</sup> statistic, which ideally but not necessarily should be below 75% (<a href="./references#CD010358-bbs2-0071" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). Additionally, a meta‐analysis would be appropriate only if the amount of information was sufficient (size and number of trials) (<a href="./references#CD010358-bbs2-0071" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD010358-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to detect publication bias (forming part of small‐study effects) by creating funnel plots for our primary outcomes. As fewer than 10 studies were included in this review (seven included), we were not able to create a funnel plot. (See <a href="#CD010358-sec-0124">Differences between protocol and review</a> for the methods we will apply if future updates of this review include enough studies to permit use of a funnel plot.) </p> </section> <section id="CD010358-sec-0056"> <h4 class="title">Data synthesis</h4> <p>As mentioned in the <a href="#CD010358-sec-0054">Assessment of heterogeneity</a> section, we planned to perform a meta‐analysis if heterogeneity was not considerable. However, because of either a small number of studies or considerable heterogeneity, we performed no meta‐analyses. (See <a href="#CD010358-sec-0124">Differences between protocol and review</a> for the methods that will be applied if future updates of this review permit meta‐analyses.) </p> <p>Among our selected outcomes, we did not expect post‐interventional complications and adverse effects to be suitable for a meta‐analysis or for inclusion in the 'Summary of findings' table. Instead, we intended to prepare a narrative report. </p> </section> <section id="CD010358-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We were not able to perform subgroup analyses, as no meta‐analyses were appropriate. See <a href="#CD010358-sec-0124">Differences between protocol and review</a>. </p> </section> <section id="CD010358-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>We were not able to perform sensitivity analyses, as no meta‐analyses were appropriate. See <a href="#CD010358-sec-0124">Differences between protocol and review</a>. </p> <section id="CD010358-sec-0059"> <h5 class="title">Summary of findings</h5> <p>We used the principles of the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) system (<a href="./references#CD010358-bbs2-0070" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians. BMJ2008;336:995‐8. [MEDLINE: 18456631] '>Guyatt 2008</a>) in our review to assess the quality of the body of evidence associated with specific outcomes (amount of 'rescue' opioid, postoperative pain, postoperative sedation, PONV, time to first passage of flatus, time to first passage of stool, time to first out‐of‐bed mobilization) and to construct a 'Summary of findings' table, if possible using GRADE software. The GRADE approach appraises the quality of a body of evidence according to the extent to which confidence indicates that an estimate of effect or association reflects the item being assessed. The quality of a body of evidence considers within‐study risk of bias (methodological quality), directness of the evidence, heterogeneity of the data, precision of effect estimates and risk of publication bias. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010358-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010358-sec-0060"></div> <section id="CD010358-sec-0061"> <h3 class="title">Description of studies</h3> <section id="CD010358-sec-0062"> <h4 class="title">Results of the search</h4> <p>Our systematic search of databases revealed 2137 records, which amounted to 1883 records when duplicates were removed. By searching other resources, we identified one potentially relevant record from a reference list in the article by <a href="./references#CD010358-bbs2-0051" title="YacoutAG , OsmanHA , Abdel‐DaemMH , HammoudaSA , ElsawyMM . Effect of intravenous dexmedetomidine infusion on some proinflammatory cytokines, stress hormones and recovery profile in major abdominal surgery. Alexandria Journal of Medicine2012;48:3‐8. [DOI: 10.1016/j.aime.2011.11.001] ">Yacout 2012</a> (<a href="./references#CD010358-bbs2-0028" title="LawrenceCJ , DeLangeS . Effects of a single pre‐operative dexmedetomidine dose on isoflurane requirements and peri‐operative haemodynamic stability. Anaesthesia1997;52(8):736‐44. ">Lawrence 1997</a>), and we found six ongoing studies by searching <a href="http://www.clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>, Science Citation Index and Current Controlled Trials (<a href="./references#CD010358-bbs2-0053" title="AwadM . Intravenous dexmedetomidine for the prevention of postoperative shivering in patients undergoing general anesthesia. ClinicalTrials.gov. ">Awad 2014</a>; <a href="./references#CD010358-bbs2-0054" title="JungKT . Effect of dexmedetomidine on recovery profiles of elderly patients. ClinicalTrials.gov. ">Jung 2014</a>; <a href="./references#CD010358-bbs2-0055" title="KimYC . The effect of dexmedetomidine on postoperative analgesia. ClinicalTrials.gov. ">Kim 2014</a>; <a href="./references#CD010358-bbs2-0056" title="Multimodal Analgesic Using Morphine and COX‐2 With or Without Dexmedetomidine for Colorectal Surgery. Ongoing studyMay 2008. ">Wai 2014</a>; <a href="./references#CD010358-bbs2-0057" title="WayCC . Multimodal analgesic using morphine and COX‐2 with or without dexmedetomidine for colorectal surgery. ClinicalTrials.gov. ">Yoo 2014</a>; <a href="./references#CD010358-bbs2-0058" title="ZeeniC , SiddikS . Dexmedetomidine for postoperative analgesia after bariatric surgery. ClinicalTrials.gov. ">Zeeni 2014</a>). Of the 1890 potentially relevant records, we excluded 1783 records as not pertinent upon screening titles and abstracts. We screened 101 full‐text articles and excluded 49 for obvious reasons. Of the 58 remaining studies, we excluded 32 for specific reasons mentioned for each study under <a href="./references#CD010358-sec-0142" title="">Characteristics of excluded studies</a> and listed these in groups in the study flow diagram (<a href="#CD010358-fig-0001">Figure 1</a>). Of the remaining 26 studies, we could not classify 13 because we needed additional information from study authors (<a href="./references#CD010358-bbs2-0040" title="AltindisNT , KaraaslanD , PekerTT , OzmenS , BulbulM . Comparison of meperidine alone with meperidine plus dexmedetomidine for postoperative patient‐controlled analgesia. Neurosciences2008;13:117‐21. ">Altindis 2008</a>; <a href="./references#CD010358-bbs2-0041" title="AnvarogluR , KelsakaE , SarihasanB , DemirkayaM , UstunE , UlgerF . The effect of intravenous dexmedetomidine premedication on hemodynamic response during endotracheal intubation and extubation and postoperative analgesic consumption. Anestezi Dergisi2008;16:201‐5. ">Anvaroglu 2008</a>; <a href="./references#CD010358-bbs2-0042" title="ArainSR , RuehlowRM , UhrichTD , EbertTJ . The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesthesia and Analgesia2004;98:153‐8. ">Arain 2004</a>; <a href="./references#CD010358-bbs2-0043" title="BicerC , EsmaogluA , AkinA , BoyaciA . Dexmedetomidine and meperidine prevent postanaesthetic shivering. European Journal of Anaesthesiology2006 Feb;23(2):149‐53. ">Bicer 2006</a>; <a href="./references#CD010358-bbs2-0044" title="CeballosCM , OsorioRG . Anesthesia for bariatric surgery: fentanyl versus fentanyl and dexmedetomidina [Anestesia en cirugía bariátrica: fentanil y dexmedetomidina vs. fentanil]. Neurologia Neurocirugia y Psiquiatria2011;44:114‐21. ">Ceballos 2011</a>; <a href="./references#CD010358-bbs2-0045" title="KilicaslanN , GursoyS , KaygusuzK , ErsecanT , KafaliH , MimarogluC . The effects of dexmedetomidine on stress response and desflurane requirement. Anestezi Dergisi2006;14:237‐42. ">Kilicaslan 2006</a>; <a href="./references#CD010358-bbs2-0046" title="KordanA , GunaydinB . A comparison of the effects of different doses of dexmedetomidine on the hemodynamic response to laryngoscopy and endotracheal intubation, peroperative anesthetic requirement and recovery. Anestezi Dergisi2006;14:95‐102. ">Kordan 2006</a>; <a href="./references#CD010358-bbs2-0047" title="MizrakA , KorukS , BilgiM , KocamerB , ErkutluI , GanidagliS , et al. Pretreatment with dexmedetomidine or thiopental decreases myoclonus after etomidate: a randomized, double‐blind controlled trial. Journal of Surgical Research2010;159:e11‐e16. ">Mizrak 2010</a>; <a href="./references#CD010358-bbs2-0048" title="ScheininB , LindgrenL , RandellT , ScheininH , ScheininM . Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. British Journal of Anaesthesia1992;68:126‐31. ">Scheinin 1992</a>; <a href="./references#CD010358-bbs2-0049" title="SubasiH , KolIO , DugerC , KaygusuzK , GursoyS , MimarogluC . Effects of dexmedetomidine and remifentanil as an adjunct of TIVA with propofol. European Journal of Anaesthesiology. Conference: European Anaesthesiology Congress, EUROANAESTHESIA 2011, Amsterdam Netherlands. 2011. ">Subasi 2012</a>; <a href="./references#CD010358-bbs2-0050" title="UnlugencH , GunduzM , GulerT , YagmurO , IsikG . The effect of pre‐anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient‐controlled morphine. European Journal of Anaesthesiology2005;22(5):386‐91. [DOI: 10.1017/S0265021505000669] ">Unlugenc 2005</a>; <a href="./references#CD010358-bbs2-0051" title="YacoutAG , OsmanHA , Abdel‐DaemMH , HammoudaSA , ElsawyMM . Effect of intravenous dexmedetomidine infusion on some proinflammatory cytokines, stress hormones and recovery profile in major abdominal surgery. Alexandria Journal of Medicine2012;48:3‐8. [DOI: 10.1016/j.aime.2011.11.001] ">Yacout 2012</a>; <a href="./references#CD010358-bbs2-0052" title="YektasA . Postoperative analgesic characteristics of intrathecal adjuvant agents including ketamine, fentanyl, sufentanyl, neostigmine, dexmedetomidine, midazolame and droperidole and their effects on spinal anesthesia. Regional Anesthesia and Pain Medicine. Conference: 30th Annual European Society of Regional Anaesthesia, ESRA Congress 2011, Dresden Germany. 2011. ">Yektas 2011</a>; see <a href="./references#CD010358-sec-0143" title="">Characteristics of studies awaiting classification</a>), and we found that six were ongoing studies (see <a href="./references#CD010358-sec-0144" title="">Characteristics of ongoing studies</a>). This process resulted in inclusion of seven studies in the narrative synthesis and revealed none for inclusion in a quantitative synthesis (meta‐analysis). </p> <div class="figure" id="CD010358-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD010358-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> <p>We reran the search in May 2015. We found 250 records and identified nine new studies of interest. We listed the nine studies of interest under <a href="./references#CD010358-bbs1-0003" title="">Studies awaiting classification</a> and in <a href="#CD010358-tbl-0002">Table 1</a>, and we will incorporate them into formal review findings during the review update. </p> <div class="table" id="CD010358-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Studies awaiting classification from May 2015 search</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0064" title="ChoK , LeeW , LeeJ.H , KimMH , LeeKM . Perioperative infusion of lidocaine vs. dexmedetomidine; effect on reduction of postoperative analgesics consumption after laparoscopic cholecystectomy. European Anaesthesiology Congress, EUROANAESTHESIA 2014. Stockholm Sweden: Lippincott Williams and Wilkins, May 2014, issue 31:228. ">Cho 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Perioperative infusion of lidocaine vs dexmedetomidine; effect on reduced consumption of postoperative analgesics after laparoscopic cholecystectomy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0072" title="IbacacheM , VegaE , RampinelliI , NazarC , ElguetaF , EchevarriaG . Effect of dexmedetomidine on postoperative glucose levels and insulin secretion in obese patients with impaired glucose tolerance. European Anaesthesiology Congress, EUROANAESTHESIA 2014. Stockholm Sweden: Lippincott Williams and Wilkins, May 2014, issue 31:150. ">Ibacache 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect of dexmedetomidine on postoperative glucose levels and insulin secretion in obese patients with impaired glucose tolerance </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0073" title="JunGW , KimMS , YangHJ , SungTY , ParkDH , et al. Laparoscopic appendectomy under spinal anesthesia with dexmedetomidine infusion. Korean Society of Anesthesiologists2014;67:246‐51. ">Jun 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic appendectomy under spinal anaesthesia with dexmedetomidine infusion</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0075" title="KimJM , KilHK . Randomized comparative study on the effects of epidural dexmedetomidine on heart rate variability during general anesthesia in patients undergoing gastrectomy. European Anaesthesiology Congress, EUROANAESTHESIA 2014. Stockholm Sweden: Lippincott Williams and Wilkins, May 2014:34‐35. ">Kim JM 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized comparative study on the effects of epidural dexmedetomidine on heart rate variability during general anaesthesia in participants undergoing gastrectomy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0076" title="LeGuenM , LiuN , TounouF , AugeM , TuilO , et al. Dexmedetomidine reduces propofol and remifentanil requirements during bispectral index‐guided closed‐loop anesthesia: a double‐blind, placebo‐controlled trial. Anesthesia and AnalgesiaMay 2014;118(5):946‐55. ">Le Guen 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dexmedetomidine reduces propofol and remifentanil requirements during bispectral index‐guided closed‐loop anaesthesia: a double‐blind, placebo‐controlled trial </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0083" title="NajaZM , KhatibR , ZiadeFM , MoussaG , NajaZZ , et al. Effect of clonidine versus dexmedetomidine on pain control after laparoscopic gastric sleeve: a prospective, randomized, double‐blinded study. Medknow Publications2014;8:57‐62. ">Naja 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect of clonidine vs dexmedetomidine on pain control after laparoscopic gastric sleeve: a prospective, randomized, double‐blinded study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0087" title="SinghS , SinghV . Effect of dexmedetomidine on haemodynamics, fentanyl requirement and recovery profile in patients of laparoscopic cholecystectomy. 7th World Congress of the World Institute of Pain, WIP 2014. Maastricht Netherlands: Blackwell Publishing Inc, May 2014:95. ">Singh 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect of dexmedetomidine on haemodynamics, fentanyl requirement and recovery profile in patients with laparoscopic cholecystectomy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0091" title="WangY , XuX , LiuH , JiF . Effects of dexmedetomidine on patients undergoing radical gastrectomy. The Journal of Surgical Research2015;194:147‐53. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effects of dexmedetomidine on patients undergoing radical gastrectomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0094" title="Ziemann‐GimmelP , GoldfarbAA , KoppmanJ , MaremaRT . Opioid‐free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis. British Journal of Anaesthesia2014;112:906‐11. ">Ziemann‐Gimmel 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Opioid‐free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>We reran the search in May 2015. These potential new studies of interest published between May 2014 and May 2015 will be incorporated into formal review findings during the review update </p> </div> </div> </section> <section id="CD010358-sec-0063"> <h4 class="title">Included studies</h4> <p>We included seven studies in this review (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>; <a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>). The total number of participants was 492, and sample sizes ranged from 20 to 120 participants. After we excluded some intervention arms, our analysis included 422 participants,and sample sizes from the seven studies ranged from 20 to 80 participants. </p> <section id="CD010358-sec-0064"> <h5 class="title">Design</h5> <p>All seven studies were randomized controlled trials with parallel groups. Three trials had multiple arms: One study comprised three arms with different dosages of dexmedetomidine compared with a fourth placebo arm (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>); for our statistical analysis, we pooled the three dexmedetomidine groups. Another study compared dexmedetomidine with dexmedetomidine‐fentanyl and control (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>). To avoid a potential synergy of different medical interventions, we chose to exclude the dexmedetomidine‐fentanyl arm. The third study (<a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) compared a dexmedetomidine plus high‐dose remifentanil group versus a placebo plus high‐dose remifentanil group versus a placebo plus low‐dose remifentanil group. For this study, we excluded the latter arm to meet our eligibility criteria, with dexmedetomidine as the sole difference between groups. We included no factorial trials and no cross‐over trials. All studies were single‐centre studies. See <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a> and <a href="#CD010358-tbl-0003">Table 2</a> for additional details. These tables describe the actual design of the study, regardless of our decisions to exclude or pool intervention groups. </p> <div class="table" id="CD010358-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Baseline data and overview of characteristics of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Study (n), country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Groups (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Route and mode of administration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Type (n) and duration of surgery (minutes)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>'Rescue' analgesia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Other relevant medication</b> </p> <p><b>1. Premedication</b> </p> <p><b>2. During surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>age (years)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>weight (kg)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>height (cm)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>gender M/F (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>ASA (n)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a> (80) </p> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX (40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous bolus (0.8 μg/kg) plus infusion (0.4 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 ± 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>123 ± 27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>169 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16/14<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 26</p> <p>III: 14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic gastric bypass</p> <p>157 ± 29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PCA morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>.Dexamethazone 8 mg, midazolam 3 mg </p> <p><b>2</b>. Propofol 1447 ± 310 mg, fentanyl 199.4 ± 44.6 μg </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same volume and rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29 ± 8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119 ± 21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>168 ± 8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18/12<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 24</p> <p>III: 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic gastric bypass</p> <p>155 ± 27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PCA morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>.Dexamethazone 8 mg, midazolam 3 mg </p> <p><b>2</b>. Propofol 2162 ± 454 mg, fentanyl 362.2 ± 57.2 μg </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a> (20) </p> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous bolus (0.5 μg/kg) plus infusion (0.4 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 ± 8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>175 ± 49<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>152 ± 13<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 6</p> <p>III: 4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open gastric bypass</p> <p>234 ± 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PCA morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Midazolam 2 mg </p> <p><b>2</b>. Thiopental 2.1 ± 0.5 mg/kg, less desflurane than control group </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fentanyl (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous bolus (0.5 μg/kg) plus infusion (0.5 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39 ± 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>159 ± 27<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>152 ± 8<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 6</p> <p>III: 4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open gastric bypass</p> <p>229 ± 30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PCA morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Midazolam 2 mg </p> <p><b>2</b>. Thiopental 3.1 ± 0.6 mg/kg, more desflurane than DEX group </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a> (60) </p> <p>India</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous infusion (initiated at 0.5 and augmented to 0.6 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.2 ± 12.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57 ± 7.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐II?<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic</p> <p>cholecystectomy</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pentazocine<sup>h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Esomeprazole 40 mg </p> <p><b>2</b>. End‐inspiratory isoflurane 0.6%, pentazocine 17.9 ± 4.13 mg<sup>k</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same volume and rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.4 ± 11.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56.6 ± 7.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐II?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic</p> <p>cholecystectomy</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pentazocine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Esomeprazole 40 mg </p> <p><b>2</b>. End‐inspiratory isoflurane 1.2%, pentazocine 29.4 ± 4.27 mg </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a> (90) </p> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intrathecal</p> <p>bolus dexmedetomidine 5 µg plus bupivacaine 0.5% 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45 ± 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.8 ± 1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>164 ± 1,5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12/18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: 27<sup>e</sup> </p> <p>II: 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Major abdominal cancer<sup>g</sup> </p> <p>188 ± 53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IV tramadol if VAS pain ≥ 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Oral diazepam 5 mg </p> <p><b>2</b>. Anaesthesia not described </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX + fentanyl (30)<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intrathecal</p> <p>bolus dexmedetomidine 5 µg plus fentanyl 25 µg plus bupivacaine 0.5% 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44 ± 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73.0 ± 1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>163 ± 1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8/22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: 25</p> <p>II: 5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Major abdominal cancer</p> <p>190 ± 62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intrathecal</p> <p>bolus of bupivacaine 0.5% 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44 ± 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.8 ± 0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>163.7 ± 1.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10/20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: 26</p> <p>II: 4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Major abdominal cancer</p> <p>173 ± 62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Oral diazepam 5 mg </p> <p><b>2</b>. Anaesthesia not described </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a> (42) </p> <p>Korea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX (21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous bolus (1.0 μg/kg) plus infusion (0.5 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.1 ± 11.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>164.2 ± 6.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9/12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I:15<sup>f</sup> </p> <p>II:5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic</p> <p>cholecystectomy</p> <p>29 ± 11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Three‐step: IV ketorolac, IV tramadol, IV fentanyl at 30 minute intervals, if VAS pain &gt; 4<sup>i</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2</b>. Propofol 83 ± 23.4 mg, ketorolac 30 mg IV, dexamethasone 8 mg IV, 0.25% bupivacaine 3 mL SC and IC </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same rate and volume</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44 ± 14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68.9 ± 12.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>166.5 ± 7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10/11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: 14<sup>f</sup> </p> <p>II: 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic</p> <p>cholecystectomy</p> <p>29 ± 14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above, but propofol 117 ± 33.9 mg</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p><a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> (80) </p> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX 0.2 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous</p> <p>infusion (0.2 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>127 ± 20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>169 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 6</p> <p>III: 14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic gastric banding (12)/bypass (8)</p> <p>110 ± 62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Three‐step: IV fentanyl, PCA morphine (2 mg bolus and 10 min lock‐out), oral hydromorphone<sup>j</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Midazolam 20 µg/kg IV. Celecoxib 400 mg orally </p> <p><b>2</b>. Less desflurane than placebo group, bupivacaine 0.25% at fascial level </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX 0.4 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous</p> <p>infusion (0.4 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 ± 9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>138 ± 41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>169 ± 8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 2</p> <p>III: 18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic gastric banding (9)/bypass (11)</p> <p>107 ± 35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX 0.8 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous</p> <p>infusion (0.8 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>151 ± 36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>172 ± 13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9/11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 4</p> <p>III: 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic gastric banding (9)/bypass (11)</p> <p>111 ± 56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same rate and volume</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43 ± 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>127 ± 25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>165 ± 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 6</p> <p>III: 14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic gastric banding (9)/bypass (11)</p> <p>116 ± 52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above, but more desflurane than in DEX groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a> (120) </p> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX plus remifentanil high‐dose (40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous</p> <p>bolus DEX (1.0 μg/kg) plus infusion remifentanil (0.4 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57 ± 11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17/23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐II</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open abdominal surgery</p> <p>204 ± 18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2</b>. Less sevoflurane than in low‐dose remifentanil group </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo plus remifentanil high‐dose (40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous bolus placebo plus</p> <p>infusion remifentanil (0.4 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58 ± 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58 ± 11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18/22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐II</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open abdominal surgery</p> <p>198 ± 36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2</b>. Less sevoflurane than in low‐dose remifentanil group </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo plus remifentanil low‐dose<sup>b</sup> (40) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous bolus placebo plus</p> <p>infusion remifentanil (0.05 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56 ± 13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18/22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐II</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open abdominal surgery</p> <p>198 ± 30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2</b>. More sevoflurane than in other groups </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data are reported as mean ± SD (standard deviation). ASA and gender are reported as number (n) of participants </p> <p>ASA: American Society of Anesthesiologists Physical Status 1 to 6, where 1 = Healthy person, 2 = Mild systemic disease, 3 = Severe systemic disease, 4 = Severe systemic disease that is a constant threat to life, 5 = A moribund person who is not expected to survive without the operation, 6 = A declared brain‐dead person whose organs are being removed for donor purposes; DEX: dexmedetomidine; NR: not reported; IV: intravenous; PCA: patient‐controlled analgesia; SC: subcutaneously; IC: intracutaneously </p> <p><sup>a</sup>Probably an error in height and weight; <sup>b</sup>Data from this intervention arm were not included in our analysis; <sup>c</sup>Error in report of gender; <sup>d</sup>ASA not reported, but probably ASA I to II; <sup>e</sup>Please note that many participants were judged to be ASA I despite having abdominal cancer; <sup>f</sup>Error in reporting of ASA; <sup>g</sup>Not reported if laparoscopic or open; <sup>h</sup>Criteria for administering pentazocine described only as 'an extra dose of pentazocine on complaint of immediate postoperative pain'; <sup>i</sup>In our data and analyses, we looked only at opioid, but amount of ketorolac IV was significantly different between groups with 43.5 ± 18 mg for DEX group and 66 ± 39.6 for placebo group (P value &lt; 0.05). The amount of fentanyl was not reported, only that 2 participants from the placebo group needed it. Only amount of IV tramadol was collected by us, showing no significant difference between groups. <sup>j</sup>No other description of criteria for administering 'rescue' analgesia. In postoperative care unit (PACU), pain was evaluated every 5 to 15 minutes, but after PACU discharge, no further description; <sup>k</sup>Total dose of pentazocine was combination of intraoperative and postoperative amounts. Intraoperatively, the DEX group received pentazocine 0.3 mg/kg, whereas the placebo group received 0.5 mg/kg, and an additional bolus of 0.1 mg/kg was administered if signs of intraoperative pain </p> </div> </div> </section> <section id="CD010358-sec-0065"> <h5 class="title">Participants</h5> <p>The review analysis included 422 participants. At least 254 were women (60.2%) and 148 men (35.1%); for the last 20 participants, we noted an error in reported data (see <a href="#CD010358-tbl-0003">Table 2</a>; <a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>). Studies were conducted in Egypt (two studies, 140 participants; <a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>); USA (two studies, 100 participants; <a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>); India (one study, 60 participants; <a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>); Korea (one study, 42 participants; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>); and China (one study, 80 participants; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>). Participants' mean age ranged from 29 to 58 years with an upper limit of 66 years of age and no exact report of lower limit (inclusion criteria from 18 years of age). Types of surgery included bariatric surgery (two studies with 100 participants having a gastric bypass and one study with 80 participants having gastric banding or gastric bypass; <a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>); cholecystectomy (two studies, 102 participants; <a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>); and major abdominal cancer surgery (one study, 60 participants; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>). Four studies (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) included laparoscopic surgery (262 participants); two included open surgery (100 participants) (<a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>, <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>); and one study reported no details about type of surgery, other than that it was major abdominal cancer surgery (60 participants; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>). Studies included participants with American Society of Anesthesiologists Physical Status (ASA) I to III (the three studies with bariatric surgery included participants with ASA II to III, and the other studies included participants with ASA I to II). All studies including ASA II to III defined exclusion criteria comprising neurological, cardiovascular, respiratory, renal and hepatic disease. Other common exclusion criteria were alcohol and drug abuse and psychiatric disease. </p> <p>See <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a> and <a href="#CD010358-tbl-0003">Table 2</a> for additional details. </p> </section> <section id="CD010358-sec-0066"> <h5 class="title">Interventions</h5> <p>Six of the seven studies compared dexmedetomidine versus placebo or control (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>). One study (20 participants) compared dexmedetomidine with fentanyl (<a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>). In five of seven studies (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>; <a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>), dexmedetomidine was administered intravenously as an infusion intraoperatively (three studies initiated the infusion by a bolus; <a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>), in another study, solely as an intravenous bolus before induction of anaesthesia (<a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) and in another study (60 participants), as a bolus intrathecally before induction of anaesthesia (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>). Dosage for the intravenous bolus ranged from 0.5 μg/kg to 1.0 μg/kg. The intrathecally administered bolus was a dosage of 5 μg. Dosage of intravenous infusion ranged from 0.4 to 0.6 μg/kg/h, except for the study which included three dose regimens of 0.2, 0.4 and 0.8 μg/kg/h (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>), which were pooled to a single intervention group in our analysis. </p> <p>See <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a> and <a href="#CD010358-tbl-0003">Table 2</a> for details. The table describes the actual interventions provided in the study, regardless of our decisions to exclude or pool intervention groups. </p> </section> <section id="CD010358-sec-0067"> <h5 class="title">Outcomes</h5> <p>See <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a> and <a href="#CD010358-tbl-0003">Table 2</a> for additional details. The table describes only the outcomes relevant for our review. All studies reported other outcomes, and some studies had several primary outcomes not reported in this review. In the following paragraphs, we will present a resume of the characteristics of our primary and secondary outcomes. </p> <section id="CD010358-sec-0068"> <h6 class="title">Primary outcomes</h6> <p>Six out of seven studies contributed to our primary outcomes (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>). Time points selected for our primary outcomes showed variability as reported by included studies. We decided post hoc, but before looking further into the actual results, that variation of one, two, three and six hours was acceptable for our prespecified time points, respectively, three, six, 12 and 24 hours postoperatively. One study reported 'postoperative day one' instead of 24 hours (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>), and two studies reported the amount of 'rescue' opioid and VAS pain at two hours after surgery instead of at three hours (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>). We have reported these data without adjustments. </p> <p>Concerning the opioid‐sparing effect of dexmedetomidine or the amount of 'rescue' opioid, four studies reported monotherapy analgesic regimens consisting of PCA (patient‐controlled analgesia) morphine (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>), intravenous morphine with no further specification (<a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) and intravenous tramadol (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>). Two studies had three‐step 'rescue' analgesia regimens; one consisted of intravenous fentanyl, intravenous PCA morphine and oral hydromorphone‐acetaminophen (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>), and the other consisted of oral ketorolac, intravenous tramadol and intravenous fentanyl (<a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>). We converted all types of opioid to the equianalgesic intravenous dose of morphine on the basis of the following equivalents, when approximately: </p> <p> <ul id="CD010358-list-0005"> <li> <p>1 mg intravenous morphine <i>equals</i> </p> </li> </ul> <ul id="CD010358-list-0006"> <li> <p>21 mg intravenous tramadol (30 mg oral tramadol) <i>equals</i> </p> </li> </ul> <ul id="CD010358-list-0007"> <li> <p>0.02 mg (20 μg) intravenous fentanyl <i>equals</i> </p> </li> </ul> <ul id="CD010358-list-0008"> <li> <p>0.75 mg oral hydromorphone</p> </li> </ul> </p> <p>(<a href="http://emedicine.medscape.com/article/2138678-overview" target="_blank">emedicine.medscape.com</a>; <a href="http://globalrph.com/narcoticonv.htm" target="_blank">globalrph.com</a>; <a href="http://www.healthquality.va.gov/guidelines/Pain/cot/COT_312_SUM-er.pdf" target="_blank">healthquality.va.gov</a>; <a href="http://www.irf.dk/dk/rekommandationsliste/baggrundsnotater/nervesystemet_analgetika_og_psykofarmaka/n02a_opioder.htm" target="_blank">irf.dk</a>; <a href="http://en.wikipedia.org/wiki/equianalgesic" target="_blank">en.wikipedia.org/wiki/equianalgesic</a>; <a href="http://tramadolfacts.com" target="_blank">tramadolfacts.com</a>). </p> <p>If a study used paracetamol or a non‐steroidal anti‐inflammatory drug (NSAID), we did not include these data in our analysis but presented them only in a narrative report. One study reported only the total dose of intraoperative and postoperative pentazocine; we reported this information narratively as well, along with the outcome of proportion of participants needing 'rescue' analgesia (<a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>). </p> <p>Concerning the analgesic efficacy of dexmedetomidine measured on a visual analogue scale (VAS) for pain, one study used a verbal rating scale (VRS 0 to 10) (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>), and the other used a VAS. Two studies used median and interquartile range (IQR) (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>), which we converted to mean and standard deviation (SD), making the assumption that the distribution of VAS is symmetrical and similar to a normal distribution. The median was thus directly used as a mean, and the IQR was assumed to be equal to an SD of 1.35 (chapter 7.7.5.3. <a href="./references#CD010358-bbs2-0071" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). One study reported VAS pain at two and four hours after surgery instead of at three hours, and we chose to report the mean of these two time points. </p> </section> <section id="CD010358-sec-0069"> <h6 class="title">Secondary outcomes</h6> <p>Five studies contributed to our secondary outcomes, of which one reported time to first request of 'rescue' analgesia (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>); two reported proportion of participants needing 'rescue' analgesia (<a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>); one reported postoperative sedation 12 hours after surgery measured by the Ramsay Sedation Scale (<a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>); three reported PONV (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>); one reported time to first passage of flatus (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) and one reported time to first out‐of‐bed mobilization (reported as time to ambulation by study authors; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>). <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a> reported postoperative sedation with no time point specified and nothing else other than 'no significance between groups'. No studies reported time to first passage of stool. </p> <p>Concerning the proportion of participants with PONV, all three studies with this outcome divided PONV into participants with nausea and participants with vomiting (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>). We chose to report only on participants with nausea and excluded those with vomiting to avoid making a unit of analysis error. One study (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) reported number of participants needing 'rescue' antiemetic therapy, as well as nausea scores (verbal rating scale 0 to 10), during the first hour postoperatively. We presented this additional information narratively. </p> </section> </section> </section> <section id="CD010358-sec-0070"> <h4 class="title">Excluded studies</h4> <p>We excluded 32 studies for specific reasons mentioned under <a href="./references#CD010358-sec-0142" title="">Characteristics of excluded studies</a>. This table comprises the studies that might appear to meet eligibility criteria but were excluded after a closer look at the full‐text article. (For details of the reasons for exclusion by group, see <a href="#CD010358-fig-0001">Figure 1</a>.) </p> <p>We excluded studies without a control group. <a href="./references#CD010358-bbs2-0009" title="AkinciHA , KolIO , DugerC , KaygusuzK , GursoyS , MimarogluC . Effects of the increasing doses of dexmedetomidine on the post‐anesthetic shivering. European Journal of Anaesthesiology. Conference: European Anaesthesiology Congress, EUROANAESTHESIA 2011, Amsterdam Netherlands. 2011. ">Akinci 2011</a> exemplified this, including three intervention groups with dexmedetomidine but no control group. </p> <p>We excluded studies in which dexmedetomidine was not the sole difference between intervention groups, or in which dexmedetomidine was not compared with another single drug, to avoid any synergy between dexmedetomidine and another drug. <a href="./references#CD010358-bbs2-0029" title="MálekJ , MarecekF , HessL , KurzováA , OcadlíkM , VotavaM . A combination of dexmedetomidine with ketamine and opioids results in significant inhibition of hemodynamic changes associated with laparoscopic cholecystectomy and in prolongation of postoperative analgesia. Rozhledy v Chirurgii2010;89(5):275‐81. ">Málek 2010</a> and <a href="./references#CD010358-bbs2-0030" title="MarangoniMA , Machado CastigliaYM , Pechutti MedeirosT . Analgesic efficacy of dexmedetomidine as compared to sufentanil in intraperitoneal surgeries. Comparative study. [Eficácia analgésica da dexmedetomidina comparada ao sufentanil em cirurgias intraperitoneais. Estudo comparativo]. Revista Brasileira de Anestesiologia2005;55(1):19‐27. ">Marangoni 2005</a> exemplified this. </p> <p>We excluded studies with procedures such as hernia repair, gynaecological surgery, urological surgery, procedures to the kidneys and vascular surgery. We planned to include surgery to the spleen in our review; however no studies examined this type of procedure (except one study awaiting classification; <a href="./references#CD010358-bbs2-0050" title="UnlugencH , GunduzM , GulerT , YagmurO , IsikG . The effect of pre‐anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient‐controlled morphine. European Journal of Anaesthesiology2005;22(5):386‐91. [DOI: 10.1017/S0265021505000669] ">Unlugenc 2005</a>). <a href="./references#CD010358-bbs2-0020" title="GuptaP , JoshiS , JethavaD , KumarA . Dexmedetomidine ameliorates monitored anaesthesia care. Indian Journal of Anaesthesia2014;58(2):154‐9. ">Gupta 2014b</a> provided mixed surgery, including plastic and otorhinolaryngological surgery, but also regional 'general surgery' of about one hour duration. We contacted the study authors by email to confirm which type, but we received no reply. We excluded this study because it probably did not examine abdominal surgery. </p> <p>We excluded studies with outcomes relevant to our review if no reports described outcomes at the specific time points prespecified in our protocol (<a href="./references#CD010358-bbs2-0095" title="Jessen LundorfL , Korvenius JørgensenH , MøllerAM . Perioperative dexmedetomidine for acute pain after abdominal surgery in adults. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD010358] ">Jessen 2013</a>) ‐ with particular variance (one, two, three and six hours of variance for three, six, 12 and 24 hours, respectively). <a href="./references#CD010358-bbs2-0023" title="HarsoorS , RaniD , LathashreeS , NethraS , SudheeshK . Effect of intraoperative dexmedetomidine infusion on sevoflurane requirement and blood glucose levels during entropy‐guided general anesthesia. Journal of Anaesthesiology Clinical Pharmacology2014;30(1):25‐30. ">Harsoor 2014</a> exemplified this. </p> <section id="CD010358-sec-0071"> <h5 class="title">Studies awaiting classification</h5> <p>Thirteen studies are awaiting classification because we needed additional information from study authors,and we have had no success when attempting to correspond. (See <a href="./references#CD010358-sec-0143" title="">Characteristics of studies awaiting classification</a> for further details.) </p> <p>We would have included <a href="./references#CD010358-bbs2-0044" title="CeballosCM , OsorioRG . Anesthesia for bariatric surgery: fentanyl versus fentanyl and dexmedetomidina [Anestesia en cirugía bariátrica: fentanil y dexmedetomidina vs. fentanil]. Neurologia Neurocirugia y Psiquiatria2011;44:114‐21. ">Ceballos 2011</a> in our review, but because VAS postoperative pain was reported as a dichotomous value ('no pain' = VAS 0 to 4, 'pain' = VAS 5 to 10) and actually measured values were not included, we categorized this study as awaiting classification. Study authors did not report type or amount of 'rescue' analgesia. We contacted these authors to request the appropriate data, and if and when they reply, we will include this study in the next updated version of this review. This study also reported postoperative sedation, but not at or near a time point prespecified by our review. </p> <p><a href="./references#CD010358-bbs2-0051" title="YacoutAG , OsmanHA , Abdel‐DaemMH , HammoudaSA , ElsawyMM . Effect of intravenous dexmedetomidine infusion on some proinflammatory cytokines, stress hormones and recovery profile in major abdominal surgery. Alexandria Journal of Medicine2012;48:3‐8. [DOI: 10.1016/j.aime.2011.11.001] ">Yacout 2012</a> reported VAS pain as a mean with no variance at all (no standard deviation, P value or other). We contacted study authors without success. We could have imputed a variance, but we chose to let the study be described as unclassified, because a statistical analysis of VAS pain for this study would be problematic at any rate as the 'rescue' analgesia used was not an opioid but was ketorolac. An NSAID is not directly convertible to opioid; therefore this study did not contribute to a statistical analysis for our other main outcome, the opioid‐sparing effect of dexmedetomidine, and our two main outcomes cannot be interpreted to our satisfaction one without the other. </p> <p><a href="./references#CD010358-bbs2-0050" title="UnlugencH , GunduzM , GulerT , YagmurO , IsikG . The effect of pre‐anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient‐controlled morphine. European Journal of Anaesthesiology2005;22(5):386‐91. [DOI: 10.1017/S0265021505000669] ">Unlugenc 2005</a> included mixed surgery, including mini‐laparotomy, cholecystectomy, splenectomy and inguinal, incisional or umbilical hernia repair. We contacted study authors to request individual participant data for the three groups that did not undergo hernia repair, but without success. The same problem applied to five other studies (<a href="./references#CD010358-bbs2-0042" title="ArainSR , RuehlowRM , UhrichTD , EbertTJ . The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesthesia and Analgesia2004;98:153‐8. ">Arain 2004</a>; <a href="./references#CD010358-bbs2-0043" title="BicerC , EsmaogluA , AkinA , BoyaciA . Dexmedetomidine and meperidine prevent postanaesthetic shivering. European Journal of Anaesthesiology2006 Feb;23(2):149‐53. ">Bicer 2006</a>; <a href="./references#CD010358-bbs2-0045" title="KilicaslanN , GursoyS , KaygusuzK , ErsecanT , KafaliH , MimarogluC . The effects of dexmedetomidine on stress response and desflurane requirement. Anestezi Dergisi2006;14:237‐42. ">Kilicaslan 2006</a>; <a href="./references#CD010358-bbs2-0047" title="MizrakA , KorukS , BilgiM , KocamerB , ErkutluI , GanidagliS , et al. Pretreatment with dexmedetomidine or thiopental decreases myoclonus after etomidate: a randomized, double‐blind controlled trial. Journal of Surgical Research2010;159:e11‐e16. ">Mizrak 2010</a>; <a href="./references#CD010358-bbs2-0048" title="ScheininB , LindgrenL , RandellT , ScheininH , ScheininM . Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. British Journal of Anaesthesia1992;68:126‐31. ">Scheinin 1992</a>) for which we also contacted first authors without success. One other study looked at lower abdominal surgery without further definition (both men and women included), and we contacted the first study author for details, without success (<a href="./references#CD010358-bbs2-0040" title="AltindisNT , KaraaslanD , PekerTT , OzmenS , BulbulM . Comparison of meperidine alone with meperidine plus dexmedetomidine for postoperative patient‐controlled analgesia. Neurosciences2008;13:117‐21. ">Altindis 2008</a>). </p> <p>Four studies could not be classified because we could not retrieve the full text, and our attempts to contact study authors were unsuccessful (<a href="./references#CD010358-bbs2-0041" title="AnvarogluR , KelsakaE , SarihasanB , DemirkayaM , UstunE , UlgerF . The effect of intravenous dexmedetomidine premedication on hemodynamic response during endotracheal intubation and extubation and postoperative analgesic consumption. Anestezi Dergisi2008;16:201‐5. ">Anvaroglu 2008</a>; <a href="./references#CD010358-bbs2-0046" title="KordanA , GunaydinB . A comparison of the effects of different doses of dexmedetomidine on the hemodynamic response to laryngoscopy and endotracheal intubation, peroperative anesthetic requirement and recovery. Anestezi Dergisi2006;14:95‐102. ">Kordan 2006</a>; <a href="./references#CD010358-bbs2-0049" title="SubasiH , KolIO , DugerC , KaygusuzK , GursoyS , MimarogluC . Effects of dexmedetomidine and remifentanil as an adjunct of TIVA with propofol. European Journal of Anaesthesiology. Conference: European Anaesthesiology Congress, EUROANAESTHESIA 2011, Amsterdam Netherlands. 2011. ">Subasi 2012</a>; <a href="./references#CD010358-bbs2-0052" title="YektasA . Postoperative analgesic characteristics of intrathecal adjuvant agents including ketamine, fentanyl, sufentanyl, neostigmine, dexmedetomidine, midazolame and droperidole and their effects on spinal anesthesia. Regional Anesthesia and Pain Medicine. Conference: 30th Annual European Society of Regional Anaesthesia, ESRA Congress 2011, Dresden Germany. 2011. ">Yektas 2011</a>). </p> </section> <section id="CD010358-sec-0072"> <h5 class="title">Ongoing studies</h5> <p>We identified six ongoing studies. See <a href="./references#CD010358-sec-0144" title="">Characteristics of ongoing studies</a> for details. </p> <p><a href="./references#CD010358-bbs2-0053" title="AwadM . Intravenous dexmedetomidine for the prevention of postoperative shivering in patients undergoing general anesthesia. ClinicalTrials.gov. ">Awad 2014</a> (recruiting participants) compares three different doses of dexmedetomidine with the primary outcomes of shivering and quality of emergence from anaesthesia. This study might not be relevant for this review as no outcomes and time points seem to correspond directly to ours. The same applies to <a href="./references#CD010358-bbs2-0054" title="JungKT . Effect of dexmedetomidine on recovery profiles of elderly patients. ClinicalTrials.gov. ">Jung 2014</a>, which compared anaesthesia with (1) sevoflurane, (2) propofol and remifentanil, (3) sevoflurane and dexmedetomidine and (4) propofol, remifentanil and dexmedetomidine. Jung et al did not specify outcomes relevant for this review, other than 'safety', which we presume translates to complications or adverse effects. The type of surgery is not specified as other than abdominal surgery. <a href="./references#CD010358-bbs2-0055" title="KimYC . The effect of dexmedetomidine on postoperative analgesia. ClinicalTrials.gov. ">Kim 2014</a> is investigating the effect of dexmedetomidine in combination with fentanyl on pain after surgery for colon cancer. This study is registered as completed and has not been verified since March 2012. We await results from this study. <a href="./references#CD010358-bbs2-0056" title="Multimodal Analgesic Using Morphine and COX‐2 With or Without Dexmedetomidine for Colorectal Surgery. Ongoing studyMay 2008. ">Wai 2014</a> is investigating the effect of morphine and COX‐2 inhibitor with or without dexmedetomidine on pain after colorectal cancer surgery. These trial authors did not specify time points for assessment of postoperative pain, but given that follow‐up is five days, they probably will report values for one or more time points relevant to this review. They also report on flatus, which is a relevant outcome for our review that has been assessed by few studies. <a href="./references#CD010358-bbs2-0057" title="WayCC . Multimodal analgesic using morphine and COX‐2 with or without dexmedetomidine for colorectal surgery. ClinicalTrials.gov. ">Yoo 2014</a> is investigating the effect of dexmedetomidine on gastrointestinal function after laparoscopic gastrectomy due to gastric cancer. They have been recruiting participants since June 2014. <a href="./references#CD010358-bbs2-0058" title="ZeeniC , SiddikS . Dexmedetomidine for postoperative analgesia after bariatric surgery. ClinicalTrials.gov. ">Zeeni 2014</a> is also investigating dexmedetomidine for analgesia after bariatric surgery (laparoscopic sleeve gastrectomy). This study has several outcomes relevant to this Cochrane review, and it is currently recruiting participants (starting in August 2014); we await study results. </p> </section> </section> </section> <section id="CD010358-sec-0073"> <h3 class="title">Risk of bias in included studies</h3> <p>For a detailed argumentation for each study's risk of bias, please see the risk of bias tables under <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a>. For an overview of the risk of bias for all domains and outcomes and for all studies, please see <a href="#CD010358-fig-0002">Figure 2</a> and <a href="#CD010358-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD010358-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010358-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010358-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010358-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>Please note that the yellow colour in the figures, signifying 'unclear risk of bias', does not permit a distinction between 'not relevant' and 'not sufficient information'. </p> <section id="CD010358-sec-0074"> <h4 class="title">Allocation</h4> <p>Assessment of risk of selection bias consists of a judgement of how the random sequence was generated and how the allocation was concealed from participants and from investigators enrolling participants. </p> <p>Three out of seven studies used a computer‐generated random sequence or random number table and were judged to have low risk of bias (<a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>), whereas the remaining four studies presented insufficient information to enable us to make a judgement. Concerning allocation concealment, only one study provided enough information to allow us to make a judgement, which indicated low risk of bias (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>). </p> <p>See <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a> for additional details. </p> </section> <section id="CD010358-sec-0075"> <h4 class="title">Blinding</h4> <p>One study was convincingly double‐blinded and described details of how this was done (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>); therefore we assigned this study as having low risk of bias for all outcomes. </p> <p>Two studies included a non‐blinded anaesthesiologist but blinded participants with blinding of some of the personnel assessing outcomes (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>). A non‐blinded anaesthesiologist might lead to a difference in the administration of anaesthetics, but for one study, such a difference would lead to an underestimation of effect (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>), and for the other study, it probably would not influence effects on pain and 'rescue' analgesia postoperatively (<a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>). Therefore, both studies had low risk of bias concerning pain and 'rescue' analgesia. When it comes to post‐interventional complications and side effects, a non‐blinded anaesthesiologist caused high risk of bias for the complications reported in one study (<a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>), whereas the other study reported no complications (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>). See <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a> for additional details. </p> <p>One study was single‐blinded and reported no further details, probably including blinded participants and a non‐blinded anaesthesiologist. As the time of follow‐up was about 30 minutes postoperatively, it was probably the anaesthesiologist who assessed all postoperative outcomes. The non‐blinded anaesthesiologist might have had an influence on the measured difference in amount of analgesia given intraoperatively, but as this would lead to an underestimation of effect, risk of bias was low concerning postoperative pain and 'rescue' analgesia (<a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>). See <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a> for additional details. Three studies did not provide enough information about blinding to enable us to make a clear judgement (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>). </p> </section> <section id="CD010358-sec-0076"> <h4 class="title">Incomplete outcome data</h4> <p>All studies had low risk of bias concerning incomplete outcome data. Only <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> had excluded participants from the final analysis ‐ one in each of the three dose‐differentiated dexmedetomidine intervention groups. Exclusion was result of surgical reasons in all three cases; therefore, we have judged risk of bias as low. </p> <p>See <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a> for additional details. </p> </section> <section id="CD010358-sec-0077"> <h4 class="title">Selective reporting</h4> <p>For one of the seven included trials, we found a published protocol (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>). However, this study had unclear risk of selective reporting because outcomes prespecified in the protocol were described in very general terms only. Two outcomes seemed to be added post hoc (number of participants discharged on postoperative day one and number of days until discharge), but they were secondary outcomes and showed no significant differences between groups; therefore, risk of bias was not judged as high. </p> <p>Only one study had low risk of selective reporting bias (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>). Even though the protocol was not available, outcomes described in the study's Methods section and outcomes reported in the study's Results section corresponded. </p> <p>The remaining studies had unclear (<a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) or high risk of selective reporting bias (<a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>) because information was insufficient to enable us to make a judgement, or because substantial irregularities were apparent between what was prespecified in the Methods section and what was actually reported in the Results section. </p> <p>See <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a> for additional details. </p> </section> <section id="CD010358-sec-0078"> <h4 class="title">Other potential sources of bias</h4> <p>Two studies were judged as having high risk of other bias. <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a> had remarkably low standard deviations for the amount of 'rescue' opioid (see <a href="./references#CD010358-fig-0009" title="">Analysis 1.6</a>), making detailed information important about differences in anaesthetic agents between groups and other analgesic drugs used. Furthermore, the study provided no details about which type of surgery was performed, other than that it was major abdominal cancer surgery. We attempted, without success, to contact the first author of this study. </p> <p>We judged <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> as having high risk of other bias because criteria for the use of the three‐step 'rescue' analgesia regimen were not clearly described. Furthermore, investigators did not describe the information given to participants on how to administer the analgesia at home. Therefore, one might suspect that the study lacked control of participant compliance at home, leading to potential contamination of outcomes. This study was sponsored in part by a medical company that manufactured dexmedetomidine, but it was unclear if this relationship introduced other potential bias. We contacted the first study author to request further information, without success. </p> <p>For three studies, information was insufficient to enable us to make a clear judgement (<a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>). Two studies seemed to have no other apparent bias (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>). Only <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> reported a potential conflict of interest. </p> <p>See <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a> for additional details. </p> </section> </section> <section id="CD010358-sec-0079"> <h3 class="title" id="CD010358-sec-0079">Effects of interventions</h3> <p>See: <a href="./full#CD010358-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <p>Six (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) of the seven included studies compared dexmedetomidine with placebo, whereas one study compared dexmedetomidine with fentanyl (<a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>). </p> <p>See <a href="./full#CD010358-tbl-0001">summary of findings Table for the main comparison</a>, <a href="./references#CD010358-sec-0098" title="">Data and analyses</a> and <a href="#CD010358-tbl-0004">Table 3</a> for additional details. </p> <div class="table" id="CD010358-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Results of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Comparison: dexmedetomidine versus placebo</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Bakhamees-2007" target="_blank">Bakhamees 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Mohamed-2012" target="_blank">Mohamed 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Park-2012" target="_blank">Park 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Tufanogullari-2008" target="_blank">Tufanogullari 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Khanduja-2013" target="_blank">Khanduja 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Xiao-2013" target="_blank">Xiao 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of participants included in this review</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77 (80)<sup>i</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Rescue' morphine (intravenous, mg) 3 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐5.20 (‐5.79, ‐4.61)*<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐3.65 (‐6.04, ‐1.26)*<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Rescue' morphine (intravenous, mg) 6 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Rescue' morphine (intravenous, mg) 12 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Rescue' morphine (intravenous, mg) 24 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐12.00 (‐15.10, ‐8.90)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐7.20 (‐7.48, ‐6.92)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.10 (‐0.95, 1.15)<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐56.00 (‐112.01, 0.01)*<sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR<sup>j</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS pain 0‐100 (mm) 3 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐30.00 (‐38.25, ‐21.75)*<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.00 (‐3.29, ‐0.71)*<sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS pain 0‐100 (mm) 6 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐3.00 (‐5.95, ‐0.05)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.00 (‐11.02, 7.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS pain 0‐100 (mm) 12 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐6.00 (‐6.72, ‐5.28)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.00 (‐6.61, 2.61)<sup>j</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS pain 0‐100 (mm) 24 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.00 (2.80, ‐1.20)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐7.00 (‐19.40, 5.40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (‐12.28, 18.28)<sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.00 (‐3.94, 3.94)<sup>j</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time to first request of 'rescue' analgesia (hours, MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.07 (2.76, 3.38)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants needing 'rescue' analgesia (RR, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.93, 1.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44 (0.15, 1.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative sedation 12 hours after surgery (RSS, Ramsay Sedation Scale from 1 = Anxious to 6 = Unresponsive) (MD, 95% CI) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.60 (1.49, 1.71)†</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Porportion of participants with PONV (RR, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.12, 3.78)<sup>g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.17, 1.48)<sup>g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54 (0.33, 0.87)*<sup>g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time to first passage of flatus/stool (hours, MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (‐5.60, 15.60) <sup>h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time to first out‐of‐bed mobilization (hours, MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.33 (‐3.95, 3.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Comparison: dexmedetomidine versus fentanyl</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Feld-2006" target="_blank">Feld 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Rescue' morphine (mg) 3 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐8.50 (‐12.75, ‐4.25)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS pain 0‐100 (mm) 3 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐40.00 (‐51.53, ‐28.47)*<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>*</b> Significant difference between groups in favour of dexmedetomidine (P value &lt; 0.05) </p> <p>† Significant difference between groups in favour of control (P value &lt; 0.05)</p> <p>MD: mean difference; CI: confidence interval; VAS: visual analogue scale; RR: risk ratio; PONV: postoperative nausea and vomiting; NR: no data reported; <sup>a</sup>Time point at 2 hours after surgery; <sup>b</sup>No specific postoperative time point reported, but only 'rescue' opioid (fentanyl) during initial time in PACU, given by personnel until PCA morphine possible; <sup>c</sup>These data reflected only the amount of intravenous tramadol given to participants, if intravenous ketorolac was not efficient. The dexmedetomidine group had smaller consumption of ketorolac (mg) with a mean difference of ‐22.50 (95% CI ‐41.10 to ‐3.90). If intravenous tramadol still was not sufficient to relieve pain, fentanyl was administered. This was necessary for 2 participants only, in the placebo group, but the dose was not reported; <sup>d</sup>Time point 2 hours after surgery, and data converted from median and interquartile range (IQR) by presuming mean and median to be equal, and standard deviation times 1.35 to be equal to IQR; <sup>e</sup>Time points reported were 2 and 4 hours after surgery, and we have reported the mean; <sup>f</sup>Time point was 'postoperative day one', which could extend some hours beyond 24 hours after surgery; <sup>g</sup>Nausea and vomiting were reported separately. We reported only nausea, presuming that participants with vomiting also had nausea. <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> also found reduced need for 'rescue' antiemetics at the first postoperative day (RR 0.35, 95% CI 0.20 to 0.60) together with slightly reduced intensity of nausea on a verbal rating scale (VRS) 0‐10 compared with placebo during the first 30 minutes postoperatively; <sup>h</sup>Only report of flatus, not stool; <sup>i</sup>Postoperative data from 3 participants were excluded from the final analysis, 1 from each of the 3 intervention groups (pooled to 1 intervention group in our review), because of surgical complications discovered at the postsurgical ward. Number of participants was therefore 77 for all outcomes, except for post‐interventional complications/adverse effects, for which it was 80 (not reported in this table, but in review text); <sup>j</sup>This trial reported amount of 'rescue' morphine at 48 hours after surgery only, showing a significant difference (mg, mean, SD) between the dexmedetomidine plus high‐dose remifentanil group (54 ± 13) versus the placebo plus high‐dose remifentanil group (78 ± 24), with mean difference of ‐21.00 (95% CI ‐29.46 to ‐12.54). Reported VAS pain scores should be interpreted with this information </p> </div> </div> <section id="CD010358-sec-0080"> <h4 class="title">Comparison 1. Dexmedetomidine versus placebo</h4> <p>For all outcomes in this comparison, we considered performing meta‐analyses unsuitable. For our main outcomes at 24 hours after surgery, the quantity of data seemed sufficient to be pooled. However, for the amount of 'rescue' opioid, heterogeneity was considered substantial clinically and statistically (I<sup>2</sup> statistic = 98%); therefore a meta‐analysis was inappropriate (for additional details about clinical and methodological heterogeneity between studies, see <a href="#CD010358-sec-0091">Quality of the evidence</a>). For the outcome of postoperative pain 24 hours after surgery, four studies (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) reported data, and statistical heterogeneity was not substantial (I<sup>2</sup> statistic = 0%). Nevertheless, we considered a meta‐analysis to be inappropriate for this outcome because we judged clinical heterogeneity to be substantial. We made this judgement mainly for two reasons. </p> <p> <ul id="CD010358-list-0009"> <li> <p>When heterogeneity was considered substantial for the outcome of amount of 'rescue' analgesia, it seemed reasonable to regard VAS postoperative pain as equally heterogeneous (the studies were almost the same at 24 hours after surgery). </p> </li> <li> <p>The standard deviation reported for the study with highest statistical weight seemed clinically unrealistic (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>). </p> </li> </ul> </p> <p>For the proportion of participants with PONV, we considered a meta‐analysis inappropriate because a relatively small quantity of data was combined with imprecision in collection of results. For all other outcomes, the quantity of data was too sparse to permit meta‐analyses. </p> <p>Five studies (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) reported data for our two primary outcomes, although not for all time points, and five studies (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) contributed to some of our secondary outcomes. One study (<a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>) reported only one outcome collected by us: the proportion of participants needing 'rescue' analgesia ‐ a secondary outcome that we had not prespecified to be included in the <a href="./full#CD010358-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD010358-sec-0081"> <h5 class="title">Primary outcomes</h5> <section id="CD010358-sec-0082"> <h6 class="title">The opioid‐sparing effect of dexmedetomidine (amount of 'rescue' opioid)</h6> <p>At three hours after surgery, we found low‐quality evidence that intravenous morphine equivalent consumption was reduced with dexmedetomidine, with a mean difference of ‐5.20 mg (95% confidence interval (CI) ‐5.79 to ‐4.61) for <a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a> (80 participants) and ‐3.65 mg (95% CI ‐6.04 to ‐1.26) for <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> (77 participants) ‐ respectively, 51% and 39% reduction. I<sup>2</sup> statistic = 34%. See <a href="./references#CD010358-fig-0004" title="">Analysis 1.1</a>. We downgraded the quality of evidence by two levels because of some study limitations and imprecision (small quantity of data). </p> <p>No studies reported data for the time points six and 12 hours after surgery.</p> <p>At the time point 24 hours after surgery, we found very low‐quality evidence that intravenous morphine equivalent consumption was reduced with dexmedetomidine, with a mean difference of ‐12.00 mg (95% CI ‐15.10 to ‐8.90) ‐ a 25% reduction ‐ for <a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a> (80 participants); ‐7.20 mg (95% CI ‐7.48 to ‐6.92) ‐ a 54% reduction ‐ for <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a> (60 participants); and ‐56.00 mg (95% CI ‐112.01 to 0.01) ‐ a 26% reduction ‐ for <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> (77 participants). One study, <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a> (42 participants), was more difficult to quantify; investigators provided a three‐step analgesia regimen, with a significant difference in the need for ketorolac (first step) favouring dexmedetomidine (intravenous ketorolac, mg, mean difference (MD) ‐22.50, 95% CI ‐41.10 to ‐3.90), no significant difference in the need for tramadol (second step) (converted to intravenous morphine, mg, MD 0.10, 95%CI ‐0.95 to 1.15) and no significant difference in the number of participants requiring fentanyl (third step) (risk ratio (RR) 0.18, 95% CI 0.01 to 4.02) (see <a href="./references#CD010358-fig-0005" title="">Analysis 1.2</a>). We downgraded the quality of evidence by three levels, from high to very low, because of serious study limitations, heterogeneity (I<sup>2</sup> statistic = 98%) and imprecision of results (broad statistical variance). </p> <p>Estimated effects should be evaluated together with VAS postoperative pain; all of the above‐mentioned studies reported reduced intensity of pain with dexmedetomidine or no significant difference compared with placebo (at varying time points). See the section below. </p> </section> <section id="CD010358-sec-0083"> <h6 class="title">The analgesic efficacy of dexmedetomidine (VAS postoperative pain)</h6> <p>At three hours after surgery, we found very low‐quality evidence for a reduction in VAS postoperative pain (0 to 100 mm) with dexmedetomidine, with a mean difference of ‐30.00 mm (95% CI ‐38.25 to ‐21.75) for <a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a> (80 participants), and a clinically unimportant mean difference of ‐2.00 mm (95% CI ‐3.29 to ‐0.71) for <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a> (60 participants). See <a href="./references#CD010358-fig-0006" title="">Analysis 1.3</a>. We downgraded the quality of evidence by three levels because of serious study limitations, imprecision (small amount of data) and heterogeneity of results (I<sup>2</sup> statistic = 98%). </p> <p>At six hours after surgery, we found very low‐quality evidence for clinically unimportant mean differences in VAS postoperative pain for two studies (a slight reduction of ‐3.00 mm (95% CI ‐5.95 to ‐0.05) with dexmedetomidine for <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a> (60 participants), and a mean difference of ‐2.00 mm (95% CI ‐11.02 to 7.02) for <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a> (42 participants) favouring neither group). I<sup>2</sup> statistic = 0%. See <a href="./references#CD010358-fig-0007" title="">Analysis 1.4</a>. We assessed the quality of evidence as very low because of serious study limitations and imprecision (small quantity of data). </p> <p>At 12 hours after surgery, results were much the same as for VAS postoperative pain at six hours after surgery, with very low‐quality evidence for mean differences of less clinical importance from two studies (a modest reduction of ‐6.00 mm (95% CI ‐6.72 to ‐5.28) with dexmedetomidine for <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a> (60 participants), and a mean difference of ‐2.00 mm (95% CI ‐6.61 to 2.61) for <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a> (80 participants) favouring neither group). I<sup>2</sup> statistic = 65%. See <a href="./references#CD010358-fig-0008" title="">Analysis 1.5</a>. We downgraded the quality of evidence for the same reasons. </p> <p>At 24 hours after surgery, the quantity of data was larger than for the other time points, but the quality was equally very low for evidence of mean differences in VAS pain close to favouring neither dexmedetomidine nor placebo (‐7.00 mm (95% CI ‐19.40 to 5.40) for <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a> (42 participants), 3.00 (95% CI ‐12.28 to 18.28) for <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> (77 participants), 0.00 (95% CI ‐3.94 to 3.94) for <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a> (80 participants) and ‐2.00 (95% CI ‐2.80 to ‐1.20) for <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a> (60 participants)). I<sup>2</sup> statistic = 0%. See <a href="./references#CD010358-fig-0009" title="">Analysis 1.6</a>. The quality of evidence was downgraded by three levels because of serious study limitations, but also for the same reasons (heterogeneity and imprecision) that led to downgrading of quality of the evidence for the amount of 'rescue' analgesia at 24 hours after surgery (given that the two outcomes are closely interrelated and that studies reporting data at 24 hours after surgery were almost the same). </p> <p>As mentioned, postoperative pain effect estimates should be evaluated together with the amount of 'rescue' analgesia, and all studies reporting VAS postoperative pain also reported amount of 'rescue' analgesia to be reduced with dexmedetomidine compared with placebo (see the section above). However, the amount of 'rescue' analgesia for <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a> was reported only at 48 hours after surgery and therefore was not reported by us, but study authors' report of VAS postoperative pain at 12 and 24 hours should be interpreted together with the information that the study found a reduction in amount of 'rescue' morphine at 48 hours after surgery in favour of dexmedetomidine, with a mean difference of ‐21.00 mg (95% CI ‐29.46 to ‐12.54). </p> </section> </section> <section id="CD010358-sec-0084"> <h5 class="title">Secondary outcomes</h5> <p>Regarding time to first request of ‘rescue’ analgesia, we assessed the quality of evidence as very low for the increase in time found for dexmedetomidine, with a mean difference of 3.07 hours (95% CI 2.76 to 3.38) (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>, 60 participants). The quality of evidence was downgraded because of serious study limitations and imprecision of results (small quantity of data). </p> <p>For the proportion of participants needing ‘rescue’ analgesia, we found very low quality of evidence for effect estimates of this outcome. In one study (<a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>, 60 participants), follow‐up was very short after end of surgery (probably around 30 minutes); we did not consider this sufficient to conclude how many participants needed 'rescue' analgesia. However, had the study evaluated the time to need for 'rescue' analgesia, one might imagine that a significant effect could be found in favour of dexmedetomidine, particularly because the dexmedetomidine group received a significantly larger amount of intraoperative analgesia than the placebo group, thus underestimating the reported effect estimate (RR 0.44, 95% CI 0.15 to 1.29) in favour of dexmedetomidine for the outcome proportion of participants needing 'rescue' analgesia. The other study reporting data (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>, 77 participants) found that all participants without exception needed 'rescue' analgesia (with seven days of follow‐up); therefore we did not consider this study to be suitable for an evaluation of this outcome either, because apparently, the type of surgery and the type of anaesthesia in all circumstances would create a need for postoperative 'rescue' analgesia. </p> <p>Regarding postoperative sedation, data were reported only at 12 hours after surgery, and we found very low‐quality evidence of an increased level of sedation with dexmedetomidine, with a mean difference in Ramsay Sedation Scale (RSS) 1 to 6 of 1.60 units (95% CI 1.49 to 1.71) (<a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>, 80 participants). Reasons for downgrading one level were study limitations and imprecision of results (small quantity of data). </p> <p>For the number of participants with PONV, we found low‐quality evidence of reduced risk with dexmedetomidine in one study (RR 0.54, 95% CI 0.33 to 0.87) for <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> (77 participants) and risk ratios in two studies close to favouring neither dexmedetomidine nor placebo (RR 0.67, 95% CI 0.12 to 3.78 for <a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a> (80 participants); RR 0.50, 95% CI 0.17 to 1.48 for <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a> (60 participants)). I<sup>2</sup> statistic = 0%. See <a href="./references#CD010358-fig-0010" title="">Analysis 1.7</a>. The quality of evidence was downgraded by two levels because of study limitations and imprecision in reporting of results,as all three studies reported nausea and vomiting as separate outcomes, with the risk that some participants counted double with pooling of outcomes to PONV (unit of analysis error), or that cases were underreported if only nausea was reported as PONV. The study that found reduced risk of PONV with dexmedetomidine also found reduced need for 'rescue' antiemetics at the first postoperative day (RR 0.35, 95% CI 0.20 to 0.60) together with slightly reduced intensity of nausea on a verbal rating scale (VRS) of 0 to 10 compared with placebo during the first 30 minutes postoperatively (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>, 77 participants). </p> <p>For time to first passage of flatus (no data for stool), low‐quality evidence suggested a mean difference close to favouring neither dexmedetomidine nor placebo, with reduction in time for the placebo group of 5.00 hours (95% CI ‐5.60 to 15.60) compared with dexmedetomidine, found in the only study reporting data (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>, 77 participants). Downgrading of two levels was imposed because of imprecision (small quantity of data). </p> <p>Regarding time to first out‐of‐bed mobilization, low‐quality evidence suggested a mean difference in favour of neither dexmedetomidine nor placebo, with a mean difference of ‐0.33 hours after surgery (95% CI ‐3.95 to 3.29) for <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> (77 participants). Quality of evidence was again downgraded because of imprecision (small quantity of data). </p> <p>Concerning post‐interventional complications or adverse effects, <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> (80 participants) reported the number of participants with hypotension requiring intervention (phenylephrine) other than a decrease in anaesthetic agents and a 200 mL fluid bolus, including two participants (10%) in the dexmedetomidine (DEX) 0.2 group, four (20%) in the DEX 0.4 group and 10 (50%) in the DEX 0.8 group, with the latter showing a risk ratio of 2.50 (95% CI 0.94 to 6.66) compared with the control group with four out of 20 (20%) participants. <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> also reported that the number of participants with hypertension and/or tachycardia requiring intervention (labetalol) other than an increase in anaesthetic agents (desflurane) was three (15%) in the DEX 0.2 group, one (5%) in the DEX 0.4 group and zero out of 20 (0%) in the DEX 0.8 group, with the latter showing a risk ratio of 0.09 (95% CI 0.01 to 1.54) compared with the control group with five out of 20 participants (25%). No other studies within this comparison reported side effects not already accounted for. The quality of evidence for these side effects was considered low, with downgrading by two levels due to imprecision of results. A slight tendency toward a probable dose‐response gradient may be present, but because of imprecision of results we have not upgraded the quality of evidence. See <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a>. </p> </section> </section> <section id="CD010358-sec-0085"> <h4 class="title">Comparison 2. Dexmedetomidine versus fentanyl</h4> <p>Only one study reported data for this comparison (<a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>, 20 participants). Because of this small quantity of data, we did not present this comparison in our 'Summary of findings' table. </p> <p>For our primary outcomes, the study reported data for the time point two hours after surgery, which we have accepted as a tolerable variation from our time point of three hours after surgery. For the amount of 'rescue' analgesia, consumption of intravenous morphine was reduced with dexmedetomidine, with a mean difference of ‐8.50 mg (95% CI ‐12.75 to ‐4.25). For VAS postoperative pain, intensity was reduced with dexmedetomidine, with a mean difference of ‐40.00 mm (95% CI ‐51.53 to ‐28.47). The quality of evidence for these estimates was considered low and was downgraded by two levels because of imprecision (small quantity of data). </p> <p>For our secondary outcomes, investigators provided data only for post‐interventional complications/side effects. This study reported the number of participants with hypotension requiring intervention (epinephrine) as three out of 10 in the dexmedetomidine group versus one out of 10 in the fentanyl group (RR 3.00, 95% CI 0.37 to 24.17). Another complication reported was prolonged mechanical ventilation in one out of 10 participants in the fentanyl group versus null in the dexmedetomidine group (RR 0.33, 95% CI 0.02 to 7.32). We considered the quality of evidence for these outcomes as very low, downgraded by three levels because of high risk of bias pertaining to an unblinded anaesthesiologist (see <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a>) and because of imprecision (small quantity of data). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010358-sec-0086" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010358-sec-0086">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010358-sec-0159">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010358-sec-0086"></div> <section id="CD010358-sec-0087"> <h3 class="title" id="CD010358-sec-0087">Summary of main results</h3> <p>See <a href="./full#CD010358-tbl-0001">summary of findings Table for the main comparison</a>, <a href="#CD010358-tbl-0003">Table 2</a> and <a href="#CD010358-tbl-0004">Table 3</a> for details. </p> <p>Our systematic review included seven studies with a total population of 492 participants, and we included 422 participants in our analysis. </p> <section id="CD010358-sec-0088"> <h4 class="title">Comparison 1. Dexmedetomidine versus placebo</h4> <p>Six studies (402 participants; <a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>; <a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) compared dexmedetomidine with placebo. Most studies reporting data found a reduction in 'rescue' opioid consumption both at three hours after surgery (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) and at 24 hours after surgery (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>), together with in general no difference in visual analogue scale (VAS) postoperative pain, and the only study (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>, 80 participants) with an important difference in VAS postoperative pain found a reduction at two hours after surgery in favour of dexmedetomidine. As the result of substantial statistical and clinical heterogeneity, meta‐analyses were not appropriate, and the quality of evidence was very low according to the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) system for our two main outcomes (although low at three hours after surgery for amount of 'rescue' analgesia). Regarding our secondary outcomes,the quantity of data was too small, or the estimates too imprecise or of too poor methodological quality, to enable us to reach any robust conclusions. Regarding post‐interventional complications or side effects, data of low‐quality evidence from one study (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>, 80 participants) showed that the number of participants with hypotension requiring intervention was slightly higher in a high‐dose dexmedetomidine group (0.8 µg/kg/h) with a risk ratio of 2.50 (95% confidence interval (CI) 0.94 to 6.66), but groups with lower doses of dexmedetomidine showed no difference compared with control groups. </p> </section> <section id="CD010358-sec-0089"> <h4 class="title">Comparison 2. Dexmedetomidine versus fentanyl</h4> <p>For the comparison dexmedetomidine versus fentanyl, only one small study (<a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a>, 20 participants) reported data and found a reduction in both 'rescue' opioid consumption and VAS postoperative pain with dexmedetomidine, but follow‐up was only two hours after surgery, and the amount of evidence must be considered too small to permit a conclusion. No data for our secondary outcomes were reported for this comparison, except for some post‐interventional adverse effects that were too rare and too biased to allow a conclusion regarding differences between groups (need for prolonged mechanical ventilation and hypotension requiring intervention). </p> <p>No studies compared dexmedetomidine with interventions other than fentanyl or control.</p> </section> </section> <section id="CD010358-sec-0090"> <h3 class="title" id="CD010358-sec-0090">Overall completeness and applicability of evidence</h3> <p>The included studies covered a population not entirely applicable to and representative of the typical population one meets in a hospital setting. The total range of age was limited to 18 to 66 years, and means of age ranged from 29 to 58 years, thus leaving the effect of dexmedetomidine on the older population uninvestigated. Regarding health status, the population represented in the included studies overall was relatively free of co‐morbidity. All studies including American Society of Anesthesiologists Physical Status (ASA) III specifically excluded neurological, cardiovascular, respiratory, renal and hepatic disease. Cultures/countries were restricted to Asia, Egypt and USA. The type of surgery was exclusively elective and showed a preponderance of bariatric surgery, but also included cholecystectomy, abdominal cancer surgery and unspecified abdominal surgery; laparoscopic (≥ 262 participants) and open procedures (≥ 100 participants) were represented. </p> <p>The interventions explored by included studies consisted of varied dosages and modes of administration (bolus, infusion or both). Studies showed a preponderance of intravenous administration (six studies, 362 participants) compared with other routes (intrathecally in one study with 60 participants). </p> <p>Outcomes explored by the included studies in general were sufficiently defined and externally applicable, although some valuable details were warranted. For VAS pain, no studies specified whether it occurred at rest or at movement, and only two studies made explicit after what criteria 'rescue' analgesia were administered (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a> at VAS pain ≥ 3, <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a> at VAS pain &gt; 4). <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> described criteria for the use of patient‐controlled analgesia (PCA) morphine, but not for the other two steps in the three‐step 'rescue' analgesia regimen. Many outcomes of importance for patients were not adequately represented by the included studies, particularly outcomes requiring a longer period of follow‐up. </p> </section> <section id="CD010358-sec-0091"> <h3 class="title" id="CD010358-sec-0091">Quality of the evidence</h3> <p>For an overview of quality of evidence, see <a href="./full#CD010358-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>According to the GRADE working group (<a href="./references#CD010358-bbs2-0070" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians. BMJ2008;336:995‐8. [MEDLINE: 18456631] '>Guyatt 2008</a>; <a href="./references#CD010358-bbs2-0071" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>), we downgraded the quality of evidence according to an evaluation of methodological limitations (internal risk of bias), indirectness of evidence, heterogeneity/inconsistency of results, imprecision of results and publication bias. We upgraded quality of evidence according to any large magnitude of effect, a probable underestimation of effect or a dose‐response gradient. Please note that external validity/applicability is not part of the quality of evidence assessment. </p> <p> <ul id="CD010358-list-0010"> <li> <p>We found<i>methodological limitation</i> to be serious for one study (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>). Not only was the risk of selective reporting high as well as the risk of other bias, the precision of results was so accurate, with remarkably small standard deviations, that a far more detailed description of study methods was particularly required. Two other studies (<a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) had some, less serious, methodological limitations. For more detailed information about internal risk of bias/study limitations, see <a href="#CD010358-fig-0002">Figure 2</a>, <a href="#CD010358-fig-0003">Figure 3</a> and <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a>. </p> </li> </ul> <ul id="CD010358-list-0011"> <li> <p>Regarding <i>indirectness of evidence</i>, we found none among populations, interventions, comparisons nor outcomes. We did not regard bariatric surgery with an obese population (for three out of seven studies) as causing indirectness of evidence, but merely as providing a reason for heterogeneity in results. </p> </li> </ul> <ul id="CD010358-list-0012"> <li> <p><i>Heterogeneity</i> between studies for amount of 'rescue' analgesia after 24 hours was substantial both statistically and clinically. The amount of 'rescue' analgesia seemed very large for <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>, whereas it seemed surprisingly small for <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a> and <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>. Possible explanations may include differences in types of surgery and anaesthetic agents; different dosages, timing and route of administration for dexmedetomidine; differences in body mass index of participants and criteria for and mode of administering 'rescue' analgesia (VAS pain ≥ 3 or &gt; 4, frequency of VAS pain evaluation, self administration or administration by personnel), together with differences in the definition of time point noted at 24 hours after surgery or at 'postoperative day one' (which may include up to several additional hours). </p> </li> </ul> <ul id="CD010358-list-0013"> <li> <p><i>Imprecision of results</i> was substantial for <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>, in particular, considering the large standard deviation for the amount of 'rescue' analgesia; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a> also had considerable imprecision. All studies had a relatively small number of participants. For postoperative nausea and vomiting (PONV), imprecision of results was due to a divergent definition of PONV (all studies reported nausea and vomiting as separate outcomes;therefore, if PONV was reported as one outcome in this review, a unit of analysis error or an underreporting of cases would be committed). </p> </li> </ul> <ul id="CD010358-list-0014"> <li> <p>Regarding risk of <i>publication bias</i>, it is difficult to make a proper assessment on this topic because a funnel plot was not considered appropriate. Only one study (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) reported that it was funded in part by a manufacturer of dexmedetomidine, but we did not assess this study as having high risk of bias (see <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a>). Studies were all relatively small; therefore a small‐study effect leading to overestimation of effects cannot be ruled out. However, we did not downgrade the quality of evidence but only reported the risk narratively. Please note that publication bias pertaining to outcomes (selective reporting bias) has been evaluated under internal risk of bias (see also <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a>). </p> </li> </ul> </p> <p>Consequently, we downgraded the quality of evidence for our two main outcomes by three levels, to very low quality of evidence, signifying that "we are very uncertain about the estimate" (<a href="./references#CD010358-bbs2-0070" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians. BMJ2008;336:995‐8. [MEDLINE: 18456631] '>Guyatt 2008</a>). This downgrading was done because of serious study limitations (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>), some study limitations (<a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>), imprecision of results (<a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) and heterogeneity in effect estimates (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>). </p> </section> <section id="CD010358-sec-0092"> <h3 class="title" id="CD010358-sec-0092">Potential biases in the review process</h3> <p>A major problem for this review that may have introduced risk of bias was the great quantity of data that could not be obtained. Six additional studies met the inclusion criteria, except that the type of surgery was mixed with other than abdominal procedures. The number of participants from these studies who underwent an abdominal procedure was at least 87 and was probably around 100. We contacted authors of all of these studies to request individual participant data, without luck (<a href="./references#CD010358-bbs2-0042" title="ArainSR , RuehlowRM , UhrichTD , EbertTJ . The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesthesia and Analgesia2004;98:153‐8. ">Arain 2004</a>; <a href="./references#CD010358-bbs2-0043" title="BicerC , EsmaogluA , AkinA , BoyaciA . Dexmedetomidine and meperidine prevent postanaesthetic shivering. European Journal of Anaesthesiology2006 Feb;23(2):149‐53. ">Bicer 2006</a>; <a href="./references#CD010358-bbs2-0045" title="KilicaslanN , GursoyS , KaygusuzK , ErsecanT , KafaliH , MimarogluC . The effects of dexmedetomidine on stress response and desflurane requirement. Anestezi Dergisi2006;14:237‐42. ">Kilicaslan 2006</a>; <a href="./references#CD010358-bbs2-0047" title="MizrakA , KorukS , BilgiM , KocamerB , ErkutluI , GanidagliS , et al. Pretreatment with dexmedetomidine or thiopental decreases myoclonus after etomidate: a randomized, double‐blind controlled trial. Journal of Surgical Research2010;159:e11‐e16. ">Mizrak 2010</a>; <a href="./references#CD010358-bbs2-0048" title="ScheininB , LindgrenL , RandellT , ScheininH , ScheininM . Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. British Journal of Anaesthesia1992;68:126‐31. ">Scheinin 1992</a>; <a href="./references#CD010358-bbs2-0050" title="UnlugencH , GunduzM , GulerT , YagmurO , IsikG . The effect of pre‐anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient‐controlled morphine. European Journal of Anaesthesiology2005;22(5):386‐91. [DOI: 10.1017/S0265021505000669] ">Unlugenc 2005</a>). What added to the risk of bias were the studies for which full text could not be retrieved, or for which additional data were needed, that might have met our eligibility criteria. We contacted study authors without luck, or we found that a contact address was not retrievable (<a href="./references#CD010358-bbs2-0040" title="AltindisNT , KaraaslanD , PekerTT , OzmenS , BulbulM . Comparison of meperidine alone with meperidine plus dexmedetomidine for postoperative patient‐controlled analgesia. Neurosciences2008;13:117‐21. ">Altindis 2008</a>; <a href="./references#CD010358-bbs2-0041" title="AnvarogluR , KelsakaE , SarihasanB , DemirkayaM , UstunE , UlgerF . The effect of intravenous dexmedetomidine premedication on hemodynamic response during endotracheal intubation and extubation and postoperative analgesic consumption. Anestezi Dergisi2008;16:201‐5. ">Anvaroglu 2008</a>; <a href="./references#CD010358-bbs2-0046" title="KordanA , GunaydinB . A comparison of the effects of different doses of dexmedetomidine on the hemodynamic response to laryngoscopy and endotracheal intubation, peroperative anesthetic requirement and recovery. Anestezi Dergisi2006;14:95‐102. ">Kordan 2006</a>; <a href="./references#CD010358-bbs2-0049" title="SubasiH , KolIO , DugerC , KaygusuzK , GursoyS , MimarogluC . Effects of dexmedetomidine and remifentanil as an adjunct of TIVA with propofol. European Journal of Anaesthesiology. Conference: European Anaesthesiology Congress, EUROANAESTHESIA 2011, Amsterdam Netherlands. 2011. ">Subasi 2012</a>; <a href="./references#CD010358-bbs2-0052" title="YektasA . Postoperative analgesic characteristics of intrathecal adjuvant agents including ketamine, fentanyl, sufentanyl, neostigmine, dexmedetomidine, midazolame and droperidole and their effects on spinal anesthesia. Regional Anesthesia and Pain Medicine. Conference: 30th Annual European Society of Regional Anaesthesia, ESRA Congress 2011, Dresden Germany. 2011. ">Yektas 2011</a>). If study authors get back to us at a later stage, we will include the data in future updates of this review. </p> <p>Another point of potential dispute was that some studies were excluded even though they came close to meeting our eligibility criteria. We had prespecified some time points for some outcomes and were faced with a decision to include or exclude studies with variation in these time points. We made an arbitrary and post hoc decision about how much variation we would permit. An alternative would have been to have no prespecified time points and then combine post hoc what was presented ‐ a choice also not without risk of bias. Among both excluded studies (<a href="./references#CD010358-bbs2-0023" title="HarsoorS , RaniD , LathashreeS , NethraS , SudheeshK . Effect of intraoperative dexmedetomidine infusion on sevoflurane requirement and blood glucose levels during entropy‐guided general anesthesia. Journal of Anaesthesiology Clinical Pharmacology2014;30(1):25‐30. ">Harsoor 2014</a>) and included studies, data were not provided for some outcomes (e.g. sedation assessed immediately after surgery (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>), amount of 'rescue' analgesia reported only after 48 hours (<a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>)). Our decision about permissible variation in time points was made before we analysed data properly, thereby reducing risk of bias. </p> <p>For the outcome of proportion of participants with PONV, three studies reporting data separated PONV into two outcomes (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>). We would have to choose to add the data and risk a unit of analysis error (participants having both nausea and vomiting would count double) or to collect only data for nausea, thereby risking underreporting of the incidence of PONV. We tried to obtain information about whether participants with vomiting also were registered as having nausea, without reply. Anticipating that this probably was the case, we chose to report only data for nausea as PONV. We could have chosen to change our outcome so that 'PONV' would become 'nausea', but as this would be a post hoc decision and as PONV is a generally accepted outcome, this decision was not tempting, although it would have made our reporting precise. </p> <p>Our decision to use the GRADE system for evaluation of quality of evidence (<a href="./references#CD010358-bbs2-0070" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians. BMJ2008;336:995‐8. [MEDLINE: 18456631] '>Guyatt 2008</a>) was made primarily to follow the consensus to apply this tool in Cochrane reviews. However, for this review in which meta‐analyses were not performed, one could point to a weakness by applying this evaluation tool. Speaking of 'low quality of the evidence' and translating it into 'further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate' seems to presume that one pooled and quantifiable estimate can be found. Therefore, for outcomes for which results of studies cannot be pooled in a meta‐analysis, the terminology of the GRADE system may be less than optimal. Our decision to report GRADE Working Group grades of evidence for an outcome if only one study is reporting data can also be discussed because the GRADE system seems to draw its strength primarily as an evaluation tool across studies, inasmuch as the criteria for downgrading the quality of evidence include heterogeneity between studies and publication bias ‐ criteria that cannot be applied unless several studies present data for a particular outcome. Furthermore, when looking at our <a href="./full#CD010358-tbl-0001">summary of findings Table for the main comparison</a>, one may find it contra‐intuitive that some of our outcomes, for which the quantity of data was small, have been downgraded by only two levels, whereas other outcomes with a larger quantity of available data have been downgraded by three levels (depending on other qualitative reasons for downgrading). In other terms, the GRADE system does not distinguish between <i>quantity</i> of evidence and <i>quality</i> of evidence but rather incorporates them into one judgement. The GRADE system does not seem to incorporate the possibility of making an 'upper limit' to quality level of evidence when the quantity of data is small. For reviews with scant data, this may result in contra‐intuitive conclusions of the following nature: 'We found low quality evidence for inconclusive evidence'. </p> <p>For other potential minor biases in the review process, see also <a href="#CD010358-tbl-0005">Table 4</a>. </p> <div class="table" id="CD010358-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Potential minor biases in the review process</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Part of review process</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description of potential minor bias</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Developing the review question</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>When choosing the proportion of participants requiring 'rescue' analgesia as one of our secondary outcomes, we overlooked that this outcome might not be meaningful with a design focusing on abdominal surgery. This surgical procedure probably will for almost all participants create some need for 'rescue' analgesia, and hence, a difference between intervention groups regarding this outcome could hardly be detected. After realising this, we could have chosen to exclude this outcome, but this would make a post hoc decision after analysis of results. Had we chosen to exclude this outcome, it would have entailed exclusion of the study by <a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>, as the study did not report other relevant outcomes for our review </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Collecting data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One of our included studies was available only in Chinese (<a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>), and because our review was not funded financially, we did not purchase a professional and full translation, but only extraction of data (see <a href="./appendices#CD010358-sec-0105">Appendix 6</a>) performed on a voluntary basis by a medical expert in native Chinese within The Cochrane Collaboration. Data from tables were extracted by the first and second authors of this review, but regarding assessment of risk of bias, the study was evaluated by only one person (the translator). However, because the study reported very little information about randomization, allocation, blinding, etc, risk of bias introduced in the review process probably was of minor importance. We contacted the Chinese authors for details in English, without reply </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>To keep focus on outcomes with importance for patients, we chose to collect data about heart rate and blood pressure only if they required intervention. Therefore, reports of e.g. significant differences in heart rate or blood pressure have not been collected, unless bradycardia or hypotension requiring intervention was reported. This decision may have led to underreporting of side effects among studies inasmuch as one can imagine that a study reporting a significant difference in heart rate may have omitted data about number of participants when intervention was needed </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Presenting results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>To make the 'Summary of findings' table as simple as possible, we decided to report only our primary outcomes at the time point 24 hours after surgery. This decision may have represented selective reporting and hence introduced risk of bias, inasmuch as the decision was made after completion of data and analyses. However, all data with all time points were presented in <a href="./references#CD010358-sec-0098" title="">Data and analyses</a> and <a href="#CD010358-tbl-0004">Table 3</a> and were also mentioned in several sections </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assessing risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assessment of 'high risk of other bias' for <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> can be debated (see <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a>). This is beyond doubt a well‐conducted study with low risk of bias for all other domains, and other reviews have assessed only the study with the highest of quality scores (<a href="./references#CD010358-bbs2-0061" title="BlaudszunG , LysakowskiC , EliaN , TramèrMR . Effect of perioperative systemic alpha2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta‐analysis of randomized controlled trials. Anaesthesiology2012;116(6):1312–22. [DOI: 10.1097/ALN.0b013e31825681cb] ">Blaudszun 2012</a>; <a href="./references#CD010358-bbs2-0086" title="SchnabelA , Meyer‐FriessemCH , ReichlSU , ZahnPK , Pogatzki‐ZahnEM . Is intraoperative dexmedetomidine a new option for postoperative pain treatment? A meta‐analysis of randomized controlled trials. Pain2013;154(7):1140‐9. [DOI: 10.1016/j.pain.2013.03.029] ">Schnabel 2013</a>). We tried to contact study authors to request additional information about the three‐step 'rescue' analgesia regimen, without success </p> </td> </tr> </tbody> </table> </div> </section> <section id="CD010358-sec-0093"> <h3 class="title" id="CD010358-sec-0093">Agreements and disagreements with other studies or reviews</h3> <p>Two recent systematic reviews on the topic, both of which investigate a broader range of surgical procedures, found results much in accordance with the results of our review. </p> <p>One systematic review (<a href="./references#CD010358-bbs2-0086" title="SchnabelA , Meyer‐FriessemCH , ReichlSU , ZahnPK , Pogatzki‐ZahnEM . Is intraoperative dexmedetomidine a new option for postoperative pain treatment? A meta‐analysis of randomized controlled trials. Pain2013;154(7):1140‐9. [DOI: 10.1016/j.pain.2013.03.029] ">Schnabel 2013</a>) including 28 randomized controlled trials with 1420 participants investigated the analgesic efficacy and safety of intraoperative dexmedetomidine versus placebo or opioids in adults undergoing surgery (major or minor surgery, comprising gynaecology, ear‐nose‐throat, urology, orthopaedics, neurosurgery, abdominal surgery, heart surgery). The median quality score of data reporting was 5 (range 1 to 7) on a modified 7‐point Oxford scale. This meta‐analysis also looked at the same primary outcomes as this review, at time points of one, two, four, 24 and 48 hours after surgery. Meta‐analyses for these outcomes were appropriate only for the comparison of dexmedetomidine versus placebo. Postoperative pain (numerical rating scale (NRS) 0 to 10) was significantly reduced in the dexmedetomidine group versus the placebo group (including nine studies and 492 participants) at all time points, with a maximum mean difference of ‐1.59 (95% CI ‐2.37 to ‐0.8) at one hour after surgery, showing diminishing differences with time, with a minimum mean difference of ‐0.41 (‐0.53 to ‐0.29) at 48 hours after surgery. Postoperative morphine consumption (including 10 studies with 528 participants) was significantly reduced in the dexmedetomidine group compared with the placebo group, with mean differences increasing from ‐3.79 mg (95% CI ‐5.36 to ‐2.23) to ‐17.24 mg (95% CI ‐24.38 to ‐10.10) to ‐39.22 mg (95% CI ‐47.52 to ‐30.91) at time points two, 24 and 48 hours after surgery. We found a non‐significant reduction in the remaining time points at one and four hours after surgery. Heterogeneity was substantial (I<sup>2</sup> statistic &gt; 90%), however, for most of the time points for both outcomes. We performed several subgroup analyses, including analyses for different types of surgery, and found that for abdominal surgery, the reduction in NRS pain was smaller than for other types of surgery, whereas the significant reduction in morphine consumption was not significantly different compared with other surgical procedures. Regarding secondary outcomes, participants treated with dexmedetomidine had a non‐significant reduction in risk ratio for PONV at most time points. The review also found a significant reduction in pruritus for dexmedetomidine treated groups, but for other opioid‐related side effects, such as urinary retention and respiratory depression, data were insufficient. Intraoperative bradycardia requiring intervention (e.g. atropine) was significantly greater in participants treated with dexmedetomidine than for those given placebo (risk ratio (RR) 2.66, 95% CI 1.54 to 4.58), whereas for intraoperative hypotension, the risk ratio was not significantly higher in the dexmedetomidine treated groups (RR 1.85, 95% CI 0.83 to 4.13). </p> <p>The other systematic review and meta‐analysis (<a href="./references#CD010358-bbs2-0061" title="BlaudszunG , LysakowskiC , EliaN , TramèrMR . Effect of perioperative systemic alpha2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta‐analysis of randomized controlled trials. Anaesthesiology2012;116(6):1312–22. [DOI: 10.1097/ALN.0b013e31825681cb] ">Blaudszun 2012</a>) investigated randomized trials conducted to test any systemic alpha‐2 agonist (vs placebo or no treatment) administered perioperatively to adults undergoing non‐cardiac surgery under general anaesthesia. Inclusion criteria consisted of reported data on postoperative cumulative opioid consumption or pain intensity. Review authors included 30 studies with 1792 participants, in which clonidine (19 studies) or dexmedetomidine (11 studies) was compared with placebo (no head‐to‐head comparison of clonidine and dexmedetomidine). Types of surgery included abdominal (14 studies), hysterectomy (five), spine (four), ear–nose–throat (one), orthopaedic (one), vascular (one) and not specified (four). The median quality score was 4 (range 2 to 7) on a modified 7‐point Oxford scale. This review found a morphine‐sparing effect at 24 hours after surgery (four studies, 419 participants) with a mean difference of ‐14.5 mg (95% CI ‐22.1 to ‐6.8) for dexmedetomidine (which was greater than for clonidine at ‐4.1 mg (95% CI ‐6.0 to‐2.2), although heterogeneity was considerable (I<sup>2</sup> statistic = 91%). For VAS postoperative pain (0 to 10 cm) at 24 hours after surgery (three studies, 225 participants), a significant reduction in mean difference (‐0.6 cm, 95% CI ‐0.9 to ‐0.2; I<sup>2</sup> statistic = 33%) favoured dexmedetomidine versus placebo (approximately the same for clonidine). At 48 hours after surgery, both alpha‐2 agonists had lost their analgesic effects. The incidence of early nausea was decreased with both drugs compared with control. Only three studies reported haemodynamic side effects for dexmedetomidine, showing increased risk of postoperative bradycardia, whereas the quantity of reported data about adverse effects for clonidine was larger and showed increased risk of intraoperative and postoperative hypotension. The review authors suspected a possible element of selective reporting in the dexmedetomidine trials concerning haemodynamic adverse effects. </p> <p>It is worth mentioning the results of two of the studies awaiting classification, for which the main portion of participants underwent abdominal surgery. Both trials were included in the two reviews mentioned above. The first study (<a href="./references#CD010358-bbs2-0050" title="UnlugencH , GunduzM , GulerT , YagmurO , IsikG . The effect of pre‐anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient‐controlled morphine. European Journal of Anaesthesiology2005;22(5):386‐91. [DOI: 10.1017/S0265021505000669] ">Unlugenc 2005</a>) found results much in accordance with the results of our review, whereas the other study (<a href="./references#CD010358-bbs2-0042" title="ArainSR , RuehlowRM , UhrichTD , EbertTJ . The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesthesia and Analgesia2004;98:153‐8. ">Arain 2004</a>) found an opioid‐sparing effect of dexmedetomidine only during the first few hours after surgery. </p> <p><a href="./references#CD010358-bbs2-0050" title="UnlugencH , GunduzM , GulerT , YagmurO , IsikG . The effect of pre‐anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient‐controlled morphine. European Journal of Anaesthesiology2005;22(5):386‐91. [DOI: 10.1017/S0265021505000669] ">Unlugenc 2005</a>, a Turkish randomized controlled trial, investigated the analgesic effect of dexmedetomidine for 60 adults (18 to 64 years of age) undergoing abdominal surgery (mini‐laparotomy (three); cholecystectomy (30); splenectomy (four); inguinal, incisional or umbilical hernia repair (23)) who were classified as ASA I to II and were treated with an intravenous bolus of dexmedetomidine 1 µg/kg or placebo at 10 minutes before induction of anaesthesia. This study found a significant reduction in 'rescue' morphine consumption in favour of dexmedetomidine at time points six, 12 and 24 hours after surgery. At 24 hours after surgery, the dexmedetomidine group had received a median of PCA morphine (mg) of 23.8 (range 69.5) versus a median of 44 (range 52) in the placebo group (P value &lt; 0.01) ‐ a 28% reduction. Review authors reported no significant differences between groups in VAS pain at rest. The study found no significant differences between groups for sedation score (5 point scale), nausea score (number of participants with nausea not reported), time to extubation nor time to recovery. Opioid‐induced side effects (urinary retention or pruritus) were very few and showed no significant differences between groups. See <a href="./references#CD010358-sec-0143" title="">Characteristics of studies awaiting classification</a>. We would evaluate risk of bias for this study as low for all domains. </p> <p>The other study, <a href="./references#CD010358-bbs2-0042" title="ArainSR , RuehlowRM , UhrichTD , EbertTJ . The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesthesia and Analgesia2004;98:153‐8. ">Arain 2004</a>, a randomized controlled trial from USA, investigated the effect of dexmedetomidine (bolus 1 µg/kg and infusion 0.4 µg/kg/h, initiated 30 minutes before end of surgery) versus morphine in 34 adults (ASA I to III, mean age 60 years) undergoing intra‐abdominal (15), major orthopaedic (13) and other surgery (six). The study found no difference in the use of PCA morphine (based on frequent increments and no total) during 24 hours after stay in the post‐anaesthesia care unit (PACU), but a significant difference in the total amount of 'rescue' morphine administered by a nurse in the PACU (precise length of stay not reported) favouring dexmedetomidine (mean difference ‐4.50 mg, 95% CI ‐5.41 to ‐3.59), together with a significant reduction in the number of participants needing 'rescue' analgesia during the first 60 minutes after surgery (RR 0.07, 95% CI 0.01 to 0.43). This study found no significant differences between groups for VAS postoperative pain, sedation or nausea (follow‐up for these outcomes was only 100 minutes after surgery). Investigators reported no cardiovascular or respiratory complications requiring intervention (heart rate in PACU was significantly lower in the dexmedetomidine group; mean arterial blood pressure showed no significant differences between groups, except for a small and transient increase in mean arterial blood pressure after bolus of dexmedetomidine). We evaluated the study to have low risk of bias in most domains and no high risk of bias. See <a href="./references#CD010358-sec-0143" title="">Characteristics of studies awaiting classification</a> for additional details. </p> <p>When we look at randomized trials (including reviews of randomized trials), side effects and complications (or protection from these) associated with the use of dexmedetomidine are difficult to detect, typically because they are underpowered. A large systematic review and meta‐analysis (<a href="./references#CD010358-bbs2-0078" title="LinYY , HeB , ChenJ , WangZN . Can dexmedetomidine be a safe and efficacious sedative agent in post‐cardiac surgery patients? A meta‐analysis. Critical Care2012;16(5):R169. [DOI: 10.1186/cc11646] ">Lin 2012</a>) investigated the safety and sedative effects of dexmedetomidine compared with placebo or another sedative agent in elective cardiac surgery patients, with administration of dexmedetomidine that was not perioperative but was provided for postoperative sedation for at least six hours. This review also included studies other than randomized controlled trials (retrospective and prospective cohort studies), and the number of participants amounted to 16,818 (11 studies). The review found that dexmedetomidine was associated with shorter length of mechanical ventilation and lower risk of delirium, ventricular tachycardia and hyperglycaemia, but that the risk of bradycardia may be increased. Review authors also concluded that dexmedetomidine may not increase the risk of hypotension, atrial fibrillation, postoperative nausea and vomiting, reintubation within five days, cardiovascular complications, postoperative infection or hospital mortality. Additionally, they found no significant differences in length of intensive care unit (ICU) or hospital stay. An interesting observation was that the review found no significant differences in morphine equivalents (mean difference 0.45, 95% CI ‐1.86 to 2.77; P value = 0.70) between the included studies, which described no additional details. Although this observation was made in a very different setting and in another population than was included in our eligibility criteria, it disagrees with findings of our review and of the above‐mentioned reviews. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010358-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/urn:x-wiley:14651858:media:CD010358:CD010358-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_t/tCD010358-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD010358-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010358-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/urn:x-wiley:14651858:media:CD010358:CD010358-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_t/tCD010358-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010358-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010358-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/urn:x-wiley:14651858:media:CD010358:CD010358-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_t/tCD010358-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010358-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010358-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/urn:x-wiley:14651858:media:CD010358:CD010358-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_t/tCD010358-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus placebo, Outcome 1 Amount of 'rescue' opioid 3 hours after surgery (intravenous morphine equivalents)." data-id="CD010358-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus placebo, Outcome 1 Amount of 'rescue' opioid 3 hours after surgery (intravenous morphine equivalents). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/references#CD010358-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010358-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/urn:x-wiley:14651858:media:CD010358:CD010358-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_t/tCD010358-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus placebo, Outcome 2 Amount of 'rescue' opioid 24 hours after surgery (intravenous morphine equivalents)." data-id="CD010358-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus placebo, Outcome 2 Amount of 'rescue' opioid 24 hours after surgery (intravenous morphine equivalents). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/references#CD010358-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010358-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/urn:x-wiley:14651858:media:CD010358:CD010358-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_t/tCD010358-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus placebo, Outcome 3 Postoperative pain 3 hours after surgery (VAS 0‐100)." data-id="CD010358-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus placebo, Outcome 3 Postoperative pain 3 hours after surgery (VAS 0‐100). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/references#CD010358-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010358-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/urn:x-wiley:14651858:media:CD010358:CD010358-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_t/tCD010358-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus placebo, Outcome 4 Postoperative pain 6 hours after surgery (VAS 0‐100)." data-id="CD010358-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus placebo, Outcome 4 Postoperative pain 6 hours after surgery (VAS 0‐100). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/references#CD010358-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010358-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/urn:x-wiley:14651858:media:CD010358:CD010358-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_t/tCD010358-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus placebo, Outcome 5 Postoperative pain 12 hours after surgery (VAS 0‐100)." data-id="CD010358-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus placebo, Outcome 5 Postoperative pain 12 hours after surgery (VAS 0‐100). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/references#CD010358-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010358-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/urn:x-wiley:14651858:media:CD010358:CD010358-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_t/tCD010358-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus placebo, Outcome 6 Postoperative pain 24 hours after surgery (VAS 0‐100)." data-id="CD010358-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus placebo, Outcome 6 Postoperative pain 24 hours after surgery (VAS 0‐100). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/references#CD010358-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010358-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/urn:x-wiley:14651858:media:CD010358:CD010358-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_t/tCD010358-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dexmedetomidine versus placebo, Outcome 7 Postoperative nausea and vomiting (PONV)." data-id="CD010358-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Dexmedetomidine versus placebo, Outcome 7 Postoperative nausea and vomiting (PONV). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/references#CD010358-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/media/CDSR/CD010358/image_n/nCD010358-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010358-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Dexmedetomidine for postoperative pain</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> adults having abdominal surgery </p> <p><b>Setting:</b> hospital </p> <p><b>Intervention:</b> perioperative dexmedetomidine </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="5" rowspan="1" valign=""> <p><b>Comparison: dexmedetomidine vs placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Effect<sup>a</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Number of participants (number of studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b> Quality of evidence (GRADE)*</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Amount of 'rescue' opioid (intravenous morphine equivalents, mg) 24 hours after surgery (MD, 95% CI) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Three of four studies found a reduction in 'rescue' opioid consumption (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>). One study showed reduced need for non‐opioid analgesia in the dexmedetomidine group and no difference in consumption of 'rescue' opioid (<a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>, 42 participants) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>259 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 3 levels because of serious risk of bias (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>), serious imprecision of results (<a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) and serious inconsistency arising from heterogeneity in effect estimates </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative pain (VAS 0 to 100 mm, visual analogue scale from 0 = no pain to 100 = worst imaginable pain) 24 hours after surgery (MD, 95% CI) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No clinically important difference in VAS postoperative pain</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>259 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 3 levels because of serious risk of bias (<a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>), serious imprecision and serious inconsistency arising from heterogeneity in amount of 'rescue' analgesia between studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative sedation 12 hours after surgery (units of RSS, Ramsay Sedation Scale from 1 = Anxious or agitated or restless to 6 = Unresponsive) (MD, 95% CI) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Quantity of data was too small to allow a robust conclusion. The only study reporting data found an increased level of sedation with dexmedetomidine, with a mean difference in RSS 1 to 6 of 1.60 units (95% CI 1.49 to 1.71) (<a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>80 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 3 levels because of serious risk of bias and serious imprecision (small quantity of data) (<a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative nausea and vomiting (PONV) (RR, 95% CI)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>One study found reduced risk of PONV with dexmedetomidine (RR 0.54, 95% CI 0.33 to 0.87; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>, 77 participants) and at the same time reduced need for antiemetics. Two other studies found risk ratios of PONV close to favouring neither dexmedetomidine nor placebo (RR 0.67, 95% CI 0.12 to 3.78 for <a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>, 80 participants) (RR 0.50, 95% CI 0.17 to 1.48 for <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>, 60 participants) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>217 (3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p><b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 2 levels because of serious inconsistency in outcome definition (PONV separated in nausea and vomiting) (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>; <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) and risk of bias (<a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a>; <a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time to first passage of flatus (hours, MD, 95% CI)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Quantity of data was too small to allow a robust conclusion. The only study reporting data found no difference in time to first passage of flatus (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>77 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p><b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 2 levels because of very serious imprecision (small quantity of data)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time to first passage of stool (hours, MD, 95% CI)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time to first out‐of‐bed mobilization (hours, MD, 95% CI)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Quantity of data was too small to allow a robust conclusion. The only study reporting data found no difference in time to first out‐of‐bed mobilization (<a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a>) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>77 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p><b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 2 levels because of very serious imprecision (small quantity of data)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>MD</b> : mean difference; <b>CI</b> : confidence interval; <b>RR</b> : risk ratio; <b>NR</b>: no data reported </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>Performing meta‐analyses was not appropriate for any outcome. All studies had a relatively small number of participants and substantial heterogeneity for three main reasons: </p> <p>1. Methodological limitations in several studies (high or unclear risk of bias)</p> <p>2. Clinical variation with great difference in amount of 'rescue' analgesia, type of surgery, body mass index, route and timing of administration of dexmedetomidine and anaesthetic agents, etc </p> <p>3. Statistical variation with relatively great imprecision in results and a high I<sup>2</sup> statistic for several outcomes </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010358-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Studies awaiting classification from May 2015 search</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0064" title="ChoK , LeeW , LeeJ.H , KimMH , LeeKM . Perioperative infusion of lidocaine vs. dexmedetomidine; effect on reduction of postoperative analgesics consumption after laparoscopic cholecystectomy. European Anaesthesiology Congress, EUROANAESTHESIA 2014. Stockholm Sweden: Lippincott Williams and Wilkins, May 2014, issue 31:228. ">Cho 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Perioperative infusion of lidocaine vs dexmedetomidine; effect on reduced consumption of postoperative analgesics after laparoscopic cholecystectomy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0072" title="IbacacheM , VegaE , RampinelliI , NazarC , ElguetaF , EchevarriaG . Effect of dexmedetomidine on postoperative glucose levels and insulin secretion in obese patients with impaired glucose tolerance. European Anaesthesiology Congress, EUROANAESTHESIA 2014. Stockholm Sweden: Lippincott Williams and Wilkins, May 2014, issue 31:150. ">Ibacache 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect of dexmedetomidine on postoperative glucose levels and insulin secretion in obese patients with impaired glucose tolerance </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0073" title="JunGW , KimMS , YangHJ , SungTY , ParkDH , et al. Laparoscopic appendectomy under spinal anesthesia with dexmedetomidine infusion. Korean Society of Anesthesiologists2014;67:246‐51. ">Jun 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic appendectomy under spinal anaesthesia with dexmedetomidine infusion</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0075" title="KimJM , KilHK . Randomized comparative study on the effects of epidural dexmedetomidine on heart rate variability during general anesthesia in patients undergoing gastrectomy. European Anaesthesiology Congress, EUROANAESTHESIA 2014. Stockholm Sweden: Lippincott Williams and Wilkins, May 2014:34‐35. ">Kim JM 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized comparative study on the effects of epidural dexmedetomidine on heart rate variability during general anaesthesia in participants undergoing gastrectomy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0076" title="LeGuenM , LiuN , TounouF , AugeM , TuilO , et al. Dexmedetomidine reduces propofol and remifentanil requirements during bispectral index‐guided closed‐loop anesthesia: a double‐blind, placebo‐controlled trial. Anesthesia and AnalgesiaMay 2014;118(5):946‐55. ">Le Guen 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dexmedetomidine reduces propofol and remifentanil requirements during bispectral index‐guided closed‐loop anaesthesia: a double‐blind, placebo‐controlled trial </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0083" title="NajaZM , KhatibR , ZiadeFM , MoussaG , NajaZZ , et al. Effect of clonidine versus dexmedetomidine on pain control after laparoscopic gastric sleeve: a prospective, randomized, double‐blinded study. Medknow Publications2014;8:57‐62. ">Naja 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect of clonidine vs dexmedetomidine on pain control after laparoscopic gastric sleeve: a prospective, randomized, double‐blinded study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0087" title="SinghS , SinghV . Effect of dexmedetomidine on haemodynamics, fentanyl requirement and recovery profile in patients of laparoscopic cholecystectomy. 7th World Congress of the World Institute of Pain, WIP 2014. Maastricht Netherlands: Blackwell Publishing Inc, May 2014:95. ">Singh 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect of dexmedetomidine on haemodynamics, fentanyl requirement and recovery profile in patients with laparoscopic cholecystectomy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0091" title="WangY , XuX , LiuH , JiF . Effects of dexmedetomidine on patients undergoing radical gastrectomy. The Journal of Surgical Research2015;194:147‐53. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effects of dexmedetomidine on patients undergoing radical gastrectomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010358-bbs2-0094" title="Ziemann‐GimmelP , GoldfarbAA , KoppmanJ , MaremaRT . Opioid‐free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis. British Journal of Anaesthesia2014;112:906‐11. ">Ziemann‐Gimmel 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Opioid‐free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>We reran the search in May 2015. These potential new studies of interest published between May 2014 and May 2015 will be incorporated into formal review findings during the review update </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Studies awaiting classification from May 2015 search</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010358-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Baseline data and overview of characteristics of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Study (n), country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Groups (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Route and mode of administration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Type (n) and duration of surgery (minutes)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>'Rescue' analgesia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Other relevant medication</b> </p> <p><b>1. Premedication</b> </p> <p><b>2. During surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>age (years)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>weight (kg)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>height (cm)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>gender M/F (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>ASA (n)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010358-bbs2-0001" title="BakhameesHS , El‐HalafawyYM , El‐KerdawyHM , GoudaNM , AltemyattS . Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East Journal of Anesthesiology2007;19(3):537‐51. ">Bakhamees 2007</a> (80) </p> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX (40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous bolus (0.8 μg/kg) plus infusion (0.4 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 ± 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>123 ± 27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>169 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16/14<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 26</p> <p>III: 14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic gastric bypass</p> <p>157 ± 29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PCA morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>.Dexamethazone 8 mg, midazolam 3 mg </p> <p><b>2</b>. Propofol 1447 ± 310 mg, fentanyl 199.4 ± 44.6 μg </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same volume and rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29 ± 8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119 ± 21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>168 ± 8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18/12<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 24</p> <p>III: 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic gastric bypass</p> <p>155 ± 27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PCA morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>.Dexamethazone 8 mg, midazolam 3 mg </p> <p><b>2</b>. Propofol 2162 ± 454 mg, fentanyl 362.2 ± 57.2 μg </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010358-bbs2-0002" title="FeldJM , HoffmanWE , StechertMM , HoffmanIW , AnandaRC . Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. Journal of Clinical Anesthesia2006;18(1):24‐8. [DOI: 1016/j.jclinane.2005.05.009] ">Feld 2006</a> (20) </p> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous bolus (0.5 μg/kg) plus infusion (0.4 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 ± 8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>175 ± 49<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>152 ± 13<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 6</p> <p>III: 4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open gastric bypass</p> <p>234 ± 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PCA morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Midazolam 2 mg </p> <p><b>2</b>. Thiopental 2.1 ± 0.5 mg/kg, less desflurane than control group </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fentanyl (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous bolus (0.5 μg/kg) plus infusion (0.5 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39 ± 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>159 ± 27<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>152 ± 8<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 6</p> <p>III: 4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open gastric bypass</p> <p>229 ± 30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PCA morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Midazolam 2 mg </p> <p><b>2</b>. Thiopental 3.1 ± 0.6 mg/kg, more desflurane than DEX group </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a> (60) </p> <p>India</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous infusion (initiated at 0.5 and augmented to 0.6 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.2 ± 12.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57 ± 7.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐II?<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic</p> <p>cholecystectomy</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pentazocine<sup>h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Esomeprazole 40 mg </p> <p><b>2</b>. End‐inspiratory isoflurane 0.6%, pentazocine 17.9 ± 4.13 mg<sup>k</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same volume and rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.4 ± 11.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56.6 ± 7.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐II?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic</p> <p>cholecystectomy</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pentazocine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Esomeprazole 40 mg </p> <p><b>2</b>. End‐inspiratory isoflurane 1.2%, pentazocine 29.4 ± 4.27 mg </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD010358-bbs2-0004" title="MohamedAA , FaresKM , MohamedSA . Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician2012;15(4):339‐48. ">Mohamed 2012</a> (90) </p> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intrathecal</p> <p>bolus dexmedetomidine 5 µg plus bupivacaine 0.5% 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45 ± 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.8 ± 1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>164 ± 1,5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12/18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: 27<sup>e</sup> </p> <p>II: 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Major abdominal cancer<sup>g</sup> </p> <p>188 ± 53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IV tramadol if VAS pain ≥ 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Oral diazepam 5 mg </p> <p><b>2</b>. Anaesthesia not described </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX + fentanyl (30)<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intrathecal</p> <p>bolus dexmedetomidine 5 µg plus fentanyl 25 µg plus bupivacaine 0.5% 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44 ± 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73.0 ± 1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>163 ± 1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8/22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: 25</p> <p>II: 5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Major abdominal cancer</p> <p>190 ± 62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intrathecal</p> <p>bolus of bupivacaine 0.5% 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44 ± 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.8 ± 0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>163.7 ± 1.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10/20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: 26</p> <p>II: 4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Major abdominal cancer</p> <p>173 ± 62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Oral diazepam 5 mg </p> <p><b>2</b>. Anaesthesia not described </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD010358-bbs2-0005" title="ParkJ , CheongS , LeeK , LimS , LeeJ , ChoK , et al. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia?. Korean Journal of Anesthesiology2012;63:436‐40. [DOI: 10.4097/kjae.2012.63.5.436] ">Park 2012</a> (42) </p> <p>Korea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX (21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous bolus (1.0 μg/kg) plus infusion (0.5 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.1 ± 11.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>164.2 ± 6.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9/12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I:15<sup>f</sup> </p> <p>II:5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic</p> <p>cholecystectomy</p> <p>29 ± 11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Three‐step: IV ketorolac, IV tramadol, IV fentanyl at 30 minute intervals, if VAS pain &gt; 4<sup>i</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2</b>. Propofol 83 ± 23.4 mg, ketorolac 30 mg IV, dexamethasone 8 mg IV, 0.25% bupivacaine 3 mL SC and IC </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same rate and volume</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44 ± 14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68.9 ± 12.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>166.5 ± 7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10/11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I: 14<sup>f</sup> </p> <p>II: 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic</p> <p>cholecystectomy</p> <p>29 ± 14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above, but propofol 117 ± 33.9 mg</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p><a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> (80) </p> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX 0.2 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous</p> <p>infusion (0.2 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>127 ± 20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>169 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 6</p> <p>III: 14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic gastric banding (12)/bypass (8)</p> <p>110 ± 62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Three‐step: IV fentanyl, PCA morphine (2 mg bolus and 10 min lock‐out), oral hydromorphone<sup>j</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b>. Midazolam 20 µg/kg IV. Celecoxib 400 mg orally </p> <p><b>2</b>. Less desflurane than placebo group, bupivacaine 0.25% at fascial level </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX 0.4 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous</p> <p>infusion (0.4 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 ± 9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>138 ± 41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>169 ± 8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 2</p> <p>III: 18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic gastric banding (9)/bypass (11)</p> <p>107 ± 35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX 0.8 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous</p> <p>infusion (0.8 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>151 ± 36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>172 ± 13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9/11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 4</p> <p>III: 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic gastric banding (9)/bypass (11)</p> <p>111 ± 56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same rate and volume</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43 ± 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>127 ± 25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>165 ± 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II: 6</p> <p>III: 14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laparoscopic gastric banding (9)/bypass (11)</p> <p>116 ± 52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Same as above, but more desflurane than in DEX groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a> (120) </p> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX plus remifentanil high‐dose (40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous</p> <p>bolus DEX (1.0 μg/kg) plus infusion remifentanil (0.4 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57 ± 11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17/23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐II</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open abdominal surgery</p> <p>204 ± 18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2</b>. Less sevoflurane than in low‐dose remifentanil group </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo plus remifentanil high‐dose (40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous bolus placebo plus</p> <p>infusion remifentanil (0.4 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58 ± 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58 ± 11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18/22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐II</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open abdominal surgery</p> <p>198 ± 36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2</b>. Less sevoflurane than in low‐dose remifentanil group </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo plus remifentanil low‐dose<sup>b</sup> (40) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous bolus placebo plus</p> <p>infusion remifentanil (0.05 μg/kg/h)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56 ± 13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59 ± 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18/22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐II</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open abdominal surgery</p> <p>198 ± 30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morphine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2</b>. More sevoflurane than in other groups </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p>Data are reported as mean ± SD (standard deviation). ASA and gender are reported as number (n) of participants </p> <p>ASA: American Society of Anesthesiologists Physical Status 1 to 6, where 1 = Healthy person, 2 = Mild systemic disease, 3 = Severe systemic disease, 4 = Severe systemic disease that is a constant threat to life, 5 = A moribund person who is not expected to survive without the operation, 6 = A declared brain‐dead person whose organs are being removed for donor purposes; DEX: dexmedetomidine; NR: not reported; IV: intravenous; PCA: patient‐controlled analgesia; SC: subcutaneously; IC: intracutaneously </p> <p><sup>a</sup>Probably an error in height and weight; <sup>b</sup>Data from this intervention arm were not included in our analysis; <sup>c</sup>Error in report of gender; <sup>d</sup>ASA not reported, but probably ASA I to II; <sup>e</sup>Please note that many participants were judged to be ASA I despite having abdominal cancer; <sup>f</sup>Error in reporting of ASA; <sup>g</sup>Not reported if laparoscopic or open; <sup>h</sup>Criteria for administering pentazocine described only as 'an extra dose of pentazocine on complaint of immediate postoperative pain'; <sup>i</sup>In our data and analyses, we looked only at opioid, but amount of ketorolac IV was significantly different between groups with 43.5 ± 18 mg for DEX group and 66 ± 39.6 for placebo group (P value &lt; 0.05). The amount of fentanyl was not reported, only that 2 participants from the placebo group needed it. Only amount of IV tramadol was collected by us, showing no significant difference between groups. <sup>j</sup>No other description of criteria for administering 'rescue' analgesia. In postoperative care unit (PACU), pain was evaluated every 5 to 15 minutes, but after PACU discharge, no further description; <sup>k</sup>Total dose of pentazocine was combination of intraoperative and postoperative amounts. Intraoperatively, the DEX group received pentazocine 0.3 mg/kg, whereas the placebo group received 0.5 mg/kg, and an additional bolus of 0.1 mg/kg was administered if signs of intraoperative pain </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Baseline data and overview of characteristics of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010358-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Results of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Comparison: dexmedetomidine versus placebo</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Bakhamees-2007" target="_blank">Bakhamees 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Mohamed-2012" target="_blank">Mohamed 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Park-2012" target="_blank">Park 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Tufanogullari-2008" target="_blank">Tufanogullari 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Khanduja-2013" target="_blank">Khanduja 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Xiao-2013" target="_blank">Xiao 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of participants included in this review</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77 (80)<sup>i</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Rescue' morphine (intravenous, mg) 3 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐5.20 (‐5.79, ‐4.61)*<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐3.65 (‐6.04, ‐1.26)*<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Rescue' morphine (intravenous, mg) 6 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Rescue' morphine (intravenous, mg) 12 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Rescue' morphine (intravenous, mg) 24 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐12.00 (‐15.10, ‐8.90)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐7.20 (‐7.48, ‐6.92)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.10 (‐0.95, 1.15)<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐56.00 (‐112.01, 0.01)*<sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR<sup>j</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS pain 0‐100 (mm) 3 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐30.00 (‐38.25, ‐21.75)*<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.00 (‐3.29, ‐0.71)*<sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS pain 0‐100 (mm) 6 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐3.00 (‐5.95, ‐0.05)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.00 (‐11.02, 7.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS pain 0‐100 (mm) 12 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐6.00 (‐6.72, ‐5.28)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.00 (‐6.61, 2.61)<sup>j</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS pain 0‐100 (mm) 24 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.00 (2.80, ‐1.20)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐7.00 (‐19.40, 5.40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (‐12.28, 18.28)<sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.00 (‐3.94, 3.94)<sup>j</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time to first request of 'rescue' analgesia (hours, MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.07 (2.76, 3.38)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants needing 'rescue' analgesia (RR, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.93, 1.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44 (0.15, 1.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative sedation 12 hours after surgery (RSS, Ramsay Sedation Scale from 1 = Anxious to 6 = Unresponsive) (MD, 95% CI) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.60 (1.49, 1.71)†</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Porportion of participants with PONV (RR, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.12, 3.78)<sup>g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.17, 1.48)<sup>g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54 (0.33, 0.87)*<sup>g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time to first passage of flatus/stool (hours, MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (‐5.60, 15.60) <sup>h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time to first out‐of‐bed mobilization (hours, MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.33 (‐3.95, 3.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Comparison: dexmedetomidine versus fentanyl</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1409242124134944014754522455914%26format=REVMAN_NOTES#STD-Feld-2006" target="_blank">Feld 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>'Rescue' morphine (mg) 3 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐8.50 (‐12.75, ‐4.25)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS pain 0‐100 (mm) 3 hours after surgery (MD, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐40.00 (‐51.53, ‐28.47)*<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><b>*</b> Significant difference between groups in favour of dexmedetomidine (P value &lt; 0.05) </p> <p>† Significant difference between groups in favour of control (P value &lt; 0.05)</p> <p>MD: mean difference; CI: confidence interval; VAS: visual analogue scale; RR: risk ratio; PONV: postoperative nausea and vomiting; NR: no data reported; <sup>a</sup>Time point at 2 hours after surgery; <sup>b</sup>No specific postoperative time point reported, but only 'rescue' opioid (fentanyl) during initial time in PACU, given by personnel until PCA morphine possible; <sup>c</sup>These data reflected only the amount of intravenous tramadol given to participants, if intravenous ketorolac was not efficient. The dexmedetomidine group had smaller consumption of ketorolac (mg) with a mean difference of ‐22.50 (95% CI ‐41.10 to ‐3.90). If intravenous tramadol still was not sufficient to relieve pain, fentanyl was administered. This was necessary for 2 participants only, in the placebo group, but the dose was not reported; <sup>d</sup>Time point 2 hours after surgery, and data converted from median and interquartile range (IQR) by presuming mean and median to be equal, and standard deviation times 1.35 to be equal to IQR; <sup>e</sup>Time points reported were 2 and 4 hours after surgery, and we have reported the mean; <sup>f</sup>Time point was 'postoperative day one', which could extend some hours beyond 24 hours after surgery; <sup>g</sup>Nausea and vomiting were reported separately. We reported only nausea, presuming that participants with vomiting also had nausea. <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> also found reduced need for 'rescue' antiemetics at the first postoperative day (RR 0.35, 95% CI 0.20 to 0.60) together with slightly reduced intensity of nausea on a verbal rating scale (VRS) 0‐10 compared with placebo during the first 30 minutes postoperatively; <sup>h</sup>Only report of flatus, not stool; <sup>i</sup>Postoperative data from 3 participants were excluded from the final analysis, 1 from each of the 3 intervention groups (pooled to 1 intervention group in our review), because of surgical complications discovered at the postsurgical ward. Number of participants was therefore 77 for all outcomes, except for post‐interventional complications/adverse effects, for which it was 80 (not reported in this table, but in review text); <sup>j</sup>This trial reported amount of 'rescue' morphine at 48 hours after surgery only, showing a significant difference (mg, mean, SD) between the dexmedetomidine plus high‐dose remifentanil group (54 ± 13) versus the placebo plus high‐dose remifentanil group (78 ± 24), with mean difference of ‐21.00 (95% CI ‐29.46 to ‐12.54). Reported VAS pain scores should be interpreted with this information </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Results of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010358-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Potential minor biases in the review process</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Part of review process</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description of potential minor bias</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Developing the review question</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>When choosing the proportion of participants requiring 'rescue' analgesia as one of our secondary outcomes, we overlooked that this outcome might not be meaningful with a design focusing on abdominal surgery. This surgical procedure probably will for almost all participants create some need for 'rescue' analgesia, and hence, a difference between intervention groups regarding this outcome could hardly be detected. After realising this, we could have chosen to exclude this outcome, but this would make a post hoc decision after analysis of results. Had we chosen to exclude this outcome, it would have entailed exclusion of the study by <a href="./references#CD010358-bbs2-0003" title="KhandujaS , OhriA , PanwarM . Dexmedetomidine reduces dose requirement of thiopentone sodium and pentazocine, decreases postoperative pain and reduces haemodynamic fluctuation. Journal of Anaesthesiology Clinical Pharmacology2014;30(2):208‐12. [DOI: 10.4103/0970‐9185.130022] ">Khanduja 2013</a>, as the study did not report other relevant outcomes for our review </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Collecting data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One of our included studies was available only in Chinese (<a href="./references#CD010358-bbs2-0007" title="XiaoC , LuB , YaoJ , SunJ . Effect of dexmedetomidine in acute postoperative pain relief is independent of suppressing the hyperalgesia induced by remifentanil. The National Medical Journal of China2013;93(1):44‐7. [DOI: 10.3760] ">Xiao 2013</a>), and because our review was not funded financially, we did not purchase a professional and full translation, but only extraction of data (see <a href="./appendices#CD010358-sec-0105">Appendix 6</a>) performed on a voluntary basis by a medical expert in native Chinese within The Cochrane Collaboration. Data from tables were extracted by the first and second authors of this review, but regarding assessment of risk of bias, the study was evaluated by only one person (the translator). However, because the study reported very little information about randomization, allocation, blinding, etc, risk of bias introduced in the review process probably was of minor importance. We contacted the Chinese authors for details in English, without reply </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>To keep focus on outcomes with importance for patients, we chose to collect data about heart rate and blood pressure only if they required intervention. Therefore, reports of e.g. significant differences in heart rate or blood pressure have not been collected, unless bradycardia or hypotension requiring intervention was reported. This decision may have led to underreporting of side effects among studies inasmuch as one can imagine that a study reporting a significant difference in heart rate may have omitted data about number of participants when intervention was needed </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Presenting results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>To make the 'Summary of findings' table as simple as possible, we decided to report only our primary outcomes at the time point 24 hours after surgery. This decision may have represented selective reporting and hence introduced risk of bias, inasmuch as the decision was made after completion of data and analyses. However, all data with all time points were presented in <a href="./references#CD010358-sec-0098" title="">Data and analyses</a> and <a href="#CD010358-tbl-0004">Table 3</a> and were also mentioned in several sections </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assessing risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assessment of 'high risk of other bias' for <a href="./references#CD010358-bbs2-0006" title="TufanogullariB , WhitePF , PeixotoMP , KianpourD , LacourT , GriffinJ , et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia &amp; Analgesia2008;106(6):1741‐8. [DOI: 10.1213/ane.0b013e318172c47c] ">Tufanogullari 2008</a> can be debated (see <a href="./references#CD010358-sec-0141" title="">Characteristics of included studies</a>). This is beyond doubt a well‐conducted study with low risk of bias for all other domains, and other reviews have assessed only the study with the highest of quality scores (<a href="./references#CD010358-bbs2-0061" title="BlaudszunG , LysakowskiC , EliaN , TramèrMR . Effect of perioperative systemic alpha2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta‐analysis of randomized controlled trials. Anaesthesiology2012;116(6):1312–22. [DOI: 10.1097/ALN.0b013e31825681cb] ">Blaudszun 2012</a>; <a href="./references#CD010358-bbs2-0086" title="SchnabelA , Meyer‐FriessemCH , ReichlSU , ZahnPK , Pogatzki‐ZahnEM . Is intraoperative dexmedetomidine a new option for postoperative pain treatment? A meta‐analysis of randomized controlled trials. Pain2013;154(7):1140‐9. [DOI: 10.1016/j.pain.2013.03.029] ">Schnabel 2013</a>). We tried to contact study authors to request additional information about the three‐step 'rescue' analgesia regimen, without success </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Potential minor biases in the review process</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/full#CD010358-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010358-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Dexmedetomidine versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amount of 'rescue' opioid 3 hours after surgery (intravenous morphine equivalents) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Amount of 'rescue' opioid 24 hours after surgery (intravenous morphine equivalents) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Postoperative pain 3 hours after surgery (VAS 0‐100) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Postoperative pain 6 hours after surgery (VAS 0‐100) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Postoperative pain 12 hours after surgery (VAS 0‐100) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Postoperative pain 24 hours after surgery (VAS 0‐100) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Postoperative nausea and vomiting (PONV) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Dexmedetomidine versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010358.pub2/references#CD010358-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010358.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010358-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010358-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010358-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD010358-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="pt#CD010358-note-0001">Português</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010358\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010358\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010358\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010358\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010358\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WbpyPs9C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010358.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010358.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010358.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010358.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010358.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724960939"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010358.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724960943"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010358.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e6f927ad91bdf',t:'MTc0MDcyNDk2MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 